{
    "src": "PMC",
    "id": "PMC8193252",
    "provider": "emerald",
    "anns": [
        {
            "exact": "Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the key enzyme in cholesterol biosynthesis.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Statins",
                    "prefix": "",
                    "postfix": " are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the key enzyme in cholesterol biosynthesis.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Statins"
                }
            ]
        },
        {
            "exact": "Their extensive use in treatment and prevention of cardiovascular diseases placed statins among the best selling drugs.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Their extensive use in treatment and prevention of cardiovascular diseases placed ",
                    "postfix": " among the best selling drugs.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "Construction of Saccharomyces cerevisiae cell factory for the production of high concentrations of natural statins will require establishment of a non-destructive self-resistance mechanism to overcome the undesirable growth inhibition effects of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Construction of Saccharomyces cerevisiae cell factory for the production of high concentrations of natural ",
                    "postfix": " will require establishment of a non-destructive self-resistance mechanism to overcome the undesirable growth inhibition effects of statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "To establish active export of statins from yeast, and thereby detoxification, we integrated a putative efflux pump-encoding gene mlcE from the mevastatin-producing Penicillium citrinum into the S. cerevisiae genome.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "To establish active export of ",
                    "postfix": " from yeast, and thereby detoxification, we integrated a putative efflux pump-encoding gene mlcE from the mevastatin-producing Penicillium citrinum into the S. cerevisiae genome.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "mevastatin-producing",
                    "prefix": "To establish active export of statins from yeast, and thereby detoxification, we integrated a putative efflux pump-encoding gene mlcE from the ",
                    "postfix": " Penicillium citrinum into the S. cerevisiae genome.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin-producing"
                }
            ]
        },
        {
            "exact": "The resulting strain showed increased resistance to both natural statins (mevastatin and lovastatin) and semi-synthetic statin (simvastatin) when compared to the wild type strain.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The resulting strain showed increased resistance to both natural statins (",
                    "postfix": " and lovastatin) and semi-synthetic statin (simvastatin) when compared to the wild type strain.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "The resulting strain showed increased resistance to both natural statins (mevastatin and ",
                    "postfix": ") and semi-synthetic statin (simvastatin) when compared to the wild type strain.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "The resulting strain showed increased resistance to both natural statins (mevastatin and lovastatin) and semi-synthetic statin (",
                    "postfix": ") when compared to the wild type strain.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "We provide a possible engineering strategy for improvement of future yeast based production of natural and semi-synthetic statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "We provide a possible engineering strategy for improvement of future yeast based production of natural and semi-synthetic ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Highlights •Yeast-based cell factory for ",
                    "postfix": " production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statins",
                    "prefix": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "Yeast-based cell factory for statin production will require a resistance mechanism.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Yeast-based cell factory for ",
                    "postfix": " production will require a resistance mechanism.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Keywords Introduction Introduction Statins are used as cholesterol-lowering drugs in treatment and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Statins",
                    "prefix": "Keywords Introduction Introduction ",
                    "postfix": " are used as cholesterol-lowering drugs in treatment and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Statins"
                }
            ]
        },
        {
            "exact": "The application of statins in medicine is based on their ability to inhibit the catalytic action of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "The application of ",
                    "postfix": " in medicine is based on their ability to inhibit the catalytic action of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Natural ",
                    "postfix": " are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "mevastatin",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; ",
                    "postfix": " (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and ",
                    "postfix": " (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Industrial scale production of natural statins and their semi-synthetic derivatives (e.g. simvastatin and pravastatin) is based on fermentation of statin-producing filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Industrial scale production of natural ",
                    "postfix": " and their semi-synthetic derivatives (e.g. simvastatin and pravastatin) is based on fermentation of statin-producing filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Industrial scale production of natural statins and their semi-synthetic derivatives (e.g. ",
                    "postfix": " and pravastatin) is based on fermentation of statin-producing filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                },
                {
                    "name": "pravastatin",
                    "prefix": "Industrial scale production of natural statins and their semi-synthetic derivatives (e.g. simvastatin and ",
                    "postfix": ") is based on fermentation of statin-producing filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=pravastatin"
                },
                {
                    "name": "statin-producing",
                    "prefix": "Industrial scale production of natural statins and their semi-synthetic derivatives (e.g. simvastatin and pravastatin) is based on fermentation of ",
                    "postfix": " filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "It will, however be crucial to establish a nondestructive resistance mechanism in yeast to overcome the undesirable growth inhibition effects of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "It will, however be crucial to establish a nondestructive resistance mechanism in yeast to overcome the undesirable growth inhibition effects of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "One such mechanism could be active export of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "One such mechanism could be active export of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "1Natural ",
                    "postfix": " and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "Mevastatin",
                    "prefix": "1Natural statins and their biosynthetic gene cluster: (A) ",
                    "postfix": " and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "(B) ",
                    "postfix": " and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "Fig. 1 Statins are used as cholesterol-lowering drugs in treatment and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Statins",
                    "prefix": "Fig. 1 ",
                    "postfix": " are used as cholesterol-lowering drugs in treatment and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Statins"
                }
            ]
        },
        {
            "exact": "The application of statins in medicine is based on their ability to inhibit the catalytic action of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "The application of ",
                    "postfix": " in medicine is based on their ability to inhibit the catalytic action of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Natural ",
                    "postfix": " are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "mevastatin",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; ",
                    "postfix": " (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and ",
                    "postfix": " (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Industrial scale production of natural statins and their semi-synthetic derivatives (e.g. simvastatin and pravastatin) is based on fermentation of statin-producing filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Industrial scale production of natural ",
                    "postfix": " and their semi-synthetic derivatives (e.g. simvastatin and pravastatin) is based on fermentation of statin-producing filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Industrial scale production of natural statins and their semi-synthetic derivatives (e.g. ",
                    "postfix": " and pravastatin) is based on fermentation of statin-producing filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                },
                {
                    "name": "pravastatin",
                    "prefix": "Industrial scale production of natural statins and their semi-synthetic derivatives (e.g. simvastatin and ",
                    "postfix": ") is based on fermentation of statin-producing filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=pravastatin"
                },
                {
                    "name": "statin-producing",
                    "prefix": "Industrial scale production of natural statins and their semi-synthetic derivatives (e.g. simvastatin and pravastatin) is based on fermentation of ",
                    "postfix": " filamentous fungi (Manzoni and Rollini, 2002, Singh and Pandey, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "It will, however be crucial to establish a nondestructive resistance mechanism in yeast to overcome the undesirable growth inhibition effects of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "It will, however be crucial to establish a nondestructive resistance mechanism in yeast to overcome the undesirable growth inhibition effects of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "One such mechanism could be active export of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "One such mechanism could be active export of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "1Natural ",
                    "postfix": " and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "Mevastatin",
                    "prefix": "1Natural statins and their biosynthetic gene cluster: (A) ",
                    "postfix": " and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "(B) ",
                    "postfix": " and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "Fig. 1 Fig. 1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Fig. 1 Fig. 1Natural ",
                    "postfix": " and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "Mevastatin",
                    "prefix": "Fig. 1 Fig. 1Natural statins and their biosynthetic gene cluster: (A) ",
                    "postfix": " and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "(B) ",
                    "postfix": " and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "Fig. 1 Fig. 1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Fig. 1 Fig. 1Natural ",
                    "postfix": " and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "Mevastatin",
                    "prefix": "Fig. 1 Fig. 1Natural statins and their biosynthetic gene cluster: (A) ",
                    "postfix": " and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "(B) ",
                    "postfix": " and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "Fig. 1 Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Fig. 1 Natural ",
                    "postfix": " and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "Mevastatin",
                    "prefix": "Fig. 1 Natural statins and their biosynthetic gene cluster: (A) ",
                    "postfix": " and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "(B) ",
                    "postfix": " and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Natural ",
                    "postfix": " and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                },
                {
                    "name": "Mevastatin",
                    "prefix": "Natural statins and their biosynthetic gene cluster: (A) ",
                    "postfix": " and its gene cluster from P. citrinum.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "(B) ",
                    "postfix": " and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "This is also likely the case for the known ",
                    "postfix": " clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "mevastatin",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the ",
                    "postfix": " cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the ",
                    "postfix": " cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Given the industrial importance of the microbial statin-producing cell factories it is surprising that only limited evidence concerning the function of the putative efflux pumps in the statin gene clusters has been provided so far.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin-producing",
                    "prefix": "Given the industrial importance of the microbial ",
                    "postfix": " cell factories it is surprising that only limited evidence concerning the function of the putative efflux pumps in the statin gene clusters has been provided so far.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                },
                {
                    "name": "statin",
                    "prefix": "Given the industrial importance of the microbial ",
                    "postfix": "-producing cell factories it is surprising that only limited evidence concerning the function of the putative efflux pumps in the statin gene clusters has been provided so far.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Hutchinson et al. found that A. terreus lovI mutants did not produce ",
                    "postfix": " or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "These findings did not clarify the function of the putative efflux pumps in the statin-producing fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin-producing",
                    "prefix": "These findings did not clarify the function of the putative efflux pumps in the ",
                    "postfix": " fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "Nevertheless, understanding the statin transport mechanism could open up an alternative avenue to classical metabolic engineering strategies aimed at increased productivity of the natural statin-producing strains (Barrios-González and Miranda, 2010).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Nevertheless, understanding the ",
                    "postfix": " transport mechanism could open up an alternative avenue to classical metabolic engineering strategies aimed at increased productivity of the natural statin-producing strains (Barrios-González and Miranda, 2010).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statin-producing",
                    "prefix": "Nevertheless, understanding the statin transport mechanism could open up an alternative avenue to classical metabolic engineering strategies aimed at increased productivity of the natural ",
                    "postfix": " strains (Barrios-González and Miranda, 2010).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Moreover, genes encoding for the ",
                    "postfix": " transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statins",
                    "prefix": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of ",
                    "postfix": " in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "This is also likely the case for the known ",
                    "postfix": " clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "mevastatin",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the ",
                    "postfix": " cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the ",
                    "postfix": " cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Given the industrial importance of the microbial statin-producing cell factories it is surprising that only limited evidence concerning the function of the putative efflux pumps in the statin gene clusters has been provided so far.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin-producing",
                    "prefix": "Given the industrial importance of the microbial ",
                    "postfix": " cell factories it is surprising that only limited evidence concerning the function of the putative efflux pumps in the statin gene clusters has been provided so far.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                },
                {
                    "name": "statin",
                    "prefix": "Given the industrial importance of the microbial ",
                    "postfix": "-producing cell factories it is surprising that only limited evidence concerning the function of the putative efflux pumps in the statin gene clusters has been provided so far.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Hutchinson et al. found that A. terreus lovI mutants did not produce ",
                    "postfix": " or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "These findings did not clarify the function of the putative efflux pumps in the statin-producing fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin-producing",
                    "prefix": "These findings did not clarify the function of the putative efflux pumps in the ",
                    "postfix": " fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "Nevertheless, understanding the statin transport mechanism could open up an alternative avenue to classical metabolic engineering strategies aimed at increased productivity of the natural statin-producing strains (Barrios-González and Miranda, 2010).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Nevertheless, understanding the ",
                    "postfix": " transport mechanism could open up an alternative avenue to classical metabolic engineering strategies aimed at increased productivity of the natural statin-producing strains (Barrios-González and Miranda, 2010).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statin-producing",
                    "prefix": "Nevertheless, understanding the statin transport mechanism could open up an alternative avenue to classical metabolic engineering strategies aimed at increased productivity of the natural ",
                    "postfix": " strains (Barrios-González and Miranda, 2010).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Moreover, genes encoding for the ",
                    "postfix": " transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statins",
                    "prefix": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of ",
                    "postfix": " in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "The E. coli transformants were selected on lysogeny broth (LB) medium containing 100 µg/mL of ampicillin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "ampicillin",
                    "prefix": "The E. coli transformants were selected on lysogeny broth (LB) medium containing 100 µg/mL of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ampicillin"
                }
            ]
        },
        {
            "exact": "The E. coli transformants were selected on lysogeny broth (LB) medium containing 100 µg/mL of ampicillin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "ampicillin",
                    "prefix": "The E. coli transformants were selected on lysogeny broth (LB) medium containing 100 µg/mL of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ampicillin"
                }
            ]
        },
        {
            "exact": "SM was prepared according to Verduyn et al. (1992), but concentrations of (NH4)2SO4 and KH2PO4 were modified to 7.5 g/L and 14.4 g/L, respectively.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "SM",
                    "prefix": "",
                    "postfix": " was prepared according to Verduyn et al. (1992), but concentrations of (NH4)2SO4 and KH2PO4 were modified to 7.5 g/L and 14.4 g/L, respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=SM"
                }
            ]
        },
        {
            "exact": "SM was supplemented with uracil (150 mg/L; Sigma-Aldrich) and l-Histidine (125 mg/L; Sigma-Aldrich) (Pronk, 2002).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "SM",
                    "prefix": "",
                    "postfix": " was supplemented with uracil (150 mg/L; Sigma-Aldrich) and l-Histidine (125 mg/L; Sigma-Aldrich) (Pronk, 2002).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=SM"
                }
            ]
        },
        {
            "exact": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "vanillin",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of ",
                    "postfix": " (320 mM), mycophenolic acid (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "mycophenolic acid",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), ",
                    "postfix": " (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mycophenolic acid"
                },
                {
                    "name": "MPA",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (",
                    "postfix": ", 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                },
                {
                    "name": "atorvastatin",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (MPA, 50 mM) and ",
                    "postfix": " (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                }
            ]
        },
        {
            "exact": "Mevastatin, lovastatin, and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Mevastatin",
                    "prefix": "",
                    "postfix": ", lovastatin, and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "Mevastatin, ",
                    "postfix": ", and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Mevastatin, lovastatin, and ",
                    "postfix": " stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Mevastatin",
                    "prefix": "",
                    "postfix": " and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                },
                {
                    "name": "atorvastatin",
                    "prefix": "Mevastatin and ",
                    "postfix": " were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, ",
                    "postfix": " from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "MPA",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, ",
                    "postfix": " and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                },
                {
                    "name": "vanillin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and ",
                    "postfix": " from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and ",
                    "postfix": " from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "SM was prepared according to Verduyn et al. (1992), but concentrations of (NH4)2SO4 and KH2PO4 were modified to 7.5 g/L and 14.4 g/L, respectively.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "SM",
                    "prefix": "",
                    "postfix": " was prepared according to Verduyn et al. (1992), but concentrations of (NH4)2SO4 and KH2PO4 were modified to 7.5 g/L and 14.4 g/L, respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=SM"
                }
            ]
        },
        {
            "exact": "SM was supplemented with uracil (150 mg/L; Sigma-Aldrich) and l-Histidine (125 mg/L; Sigma-Aldrich) (Pronk, 2002).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "SM",
                    "prefix": "",
                    "postfix": " was supplemented with uracil (150 mg/L; Sigma-Aldrich) and l-Histidine (125 mg/L; Sigma-Aldrich) (Pronk, 2002).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=SM"
                }
            ]
        },
        {
            "exact": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "vanillin",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of ",
                    "postfix": " (320 mM), mycophenolic acid (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "mycophenolic acid",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), ",
                    "postfix": " (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mycophenolic acid"
                },
                {
                    "name": "MPA",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (",
                    "postfix": ", 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                },
                {
                    "name": "atorvastatin",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (MPA, 50 mM) and ",
                    "postfix": " (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                }
            ]
        },
        {
            "exact": "Mevastatin, lovastatin, and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Mevastatin",
                    "prefix": "",
                    "postfix": ", lovastatin, and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "Mevastatin, ",
                    "postfix": ", and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Mevastatin, lovastatin, and ",
                    "postfix": " stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Mevastatin",
                    "prefix": "",
                    "postfix": " and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                },
                {
                    "name": "atorvastatin",
                    "prefix": "Mevastatin and ",
                    "postfix": " were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, ",
                    "postfix": " from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "MPA",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, ",
                    "postfix": " and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                },
                {
                    "name": "vanillin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and ",
                    "postfix": " from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and ",
                    "postfix": " from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "SM was prepared according to Verduyn et al. (1992), but concentrations of (NH4)2SO4 and KH2PO4 were modified to 7.5 g/L and 14.4 g/L, respectively.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "SM",
                    "prefix": "",
                    "postfix": " was prepared according to Verduyn et al. (1992), but concentrations of (NH4)2SO4 and KH2PO4 were modified to 7.5 g/L and 14.4 g/L, respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=SM"
                }
            ]
        },
        {
            "exact": "SM was supplemented with uracil (150 mg/L; Sigma-Aldrich) and l-Histidine (125 mg/L; Sigma-Aldrich) (Pronk, 2002).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "SM",
                    "prefix": "",
                    "postfix": " was supplemented with uracil (150 mg/L; Sigma-Aldrich) and l-Histidine (125 mg/L; Sigma-Aldrich) (Pronk, 2002).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=SM"
                }
            ]
        },
        {
            "exact": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "vanillin",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of ",
                    "postfix": " (320 mM), mycophenolic acid (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "mycophenolic acid",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), ",
                    "postfix": " (MPA, 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mycophenolic acid"
                },
                {
                    "name": "MPA",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (",
                    "postfix": ", 50 mM) and atorvastatin (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                },
                {
                    "name": "atorvastatin",
                    "prefix": "Glucose was added as carbon source to a final concentration of 20 g/L. The compounds used in the susceptibility experiments were prepared as follows: stock solutions of vanillin (320 mM), mycophenolic acid (MPA, 50 mM) and ",
                    "postfix": " (10 mM) were prepared by dissolving the compounds in 99% ethanol.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                }
            ]
        },
        {
            "exact": "Mevastatin, lovastatin, and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Mevastatin",
                    "prefix": "",
                    "postfix": ", lovastatin, and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "Mevastatin, ",
                    "postfix": ", and simvastatin stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Mevastatin, lovastatin, and ",
                    "postfix": " stock solutions (50 mM) were prepared as described previously (Morimoto et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Mevastatin",
                    "prefix": "",
                    "postfix": " and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Mevastatin"
                },
                {
                    "name": "atorvastatin",
                    "prefix": "Mevastatin and ",
                    "postfix": " were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                },
                {
                    "name": "lovastatin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, ",
                    "postfix": " from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "MPA",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, ",
                    "postfix": " and vanillin from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                },
                {
                    "name": "vanillin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and ",
                    "postfix": " from Sigma-Aldrich, and simvastatin from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Mevastatin and atorvastatin were purchased from Toronto Research Chemicals, lovastatin from Tokyo Chemical Industry, MPA and vanillin from Sigma-Aldrich, and ",
                    "postfix": " from Ark Pharm.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "For susceptibility assay in liquid medium, strains were grown aerobically in SM, containing different concentrations of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "For susceptibility assay in liquid medium, strains were grown aerobically in SM, containing different concentrations of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Cells were harvested from overnight shake flask cultures (30 °C/150 rpm) in late exponential phase and diluted to an OD600 of 0.1 in SM medium with 0.7, 1.2 or 2.0 mM of activated lovastatin or an equal volume of control solution (99% ethanol treated as described above—preparation of the compounds for the susceptibility experiments).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Cells were harvested from overnight shake flask cultures (30 °C/150 rpm) in late exponential phase and diluted to an OD600 of 0.1 in SM medium with 0.7, 1.2 or 2.0 mM of activated ",
                    "postfix": " or an equal volume of control solution (99% ethanol treated as described above—preparation of the compounds for the susceptibility experiments).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Triplicate OD600 measurements were taken every 5 min for 24 h. For susceptibility assay in liquid medium, strains were grown aerobically in SM, containing different concentrations of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Triplicate OD600 measurements were taken every 5 min for 24 h. For susceptibility assay in liquid medium, strains were grown aerobically in SM, containing different concentrations of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Cells were harvested from overnight shake flask cultures (30 °C/150 rpm) in late exponential phase and diluted to an OD600 of 0.1 in SM medium with 0.7, 1.2 or 2.0 mM of activated lovastatin or an equal volume of control solution (99% ethanol treated as described above—preparation of the compounds for the susceptibility experiments).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Cells were harvested from overnight shake flask cultures (30 °C/150 rpm) in late exponential phase and diluted to an OD600 of 0.1 in SM medium with 0.7, 1.2 or 2.0 mM of activated ",
                    "postfix": " or an equal volume of control solution (99% ethanol treated as described above—preparation of the compounds for the susceptibility experiments).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Triplicate OD600 measurements were taken every 5 min for 24 h. For susceptibility assay in liquid medium, strains were grown aerobically in SM, containing different concentrations of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Triplicate OD600 measurements were taken every 5 min for 24 h. For susceptibility assay in liquid medium, strains were grown aerobically in SM, containing different concentrations of ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Cells were harvested from overnight shake flask cultures (30 °C/150 rpm) in late exponential phase and diluted to an OD600 of 0.1 in SM medium with 0.7, 1.2 or 2.0 mM of activated lovastatin or an equal volume of control solution (99% ethanol treated as described above—preparation of the compounds for the susceptibility experiments).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Cells were harvested from overnight shake flask cultures (30 °C/150 rpm) in late exponential phase and diluted to an OD600 of 0.1 in SM medium with 0.7, 1.2 or 2.0 mM of activated ",
                    "postfix": " or an equal volume of control solution (99% ethanol treated as described above—preparation of the compounds for the susceptibility experiments).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Triplicate OD600 measurements were taken every 5 min for 24 h. Results and discussion Results and discussion Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "Triplicate OD600 measurements were taken every 5 min for 24 h. Results and discussion Results and discussion Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE MlcE, a putative efflux pump from the P. citrinum ",
                    "postfix": " biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "cercosporin",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the ",
                    "postfix": " facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cercosporin"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Fig. 2Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Fig. 2 MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "Fig. 2 MlcE, a putative efflux pump from the P. citrinum ",
                    "postfix": " biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "cercosporin",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the ",
                    "postfix": " facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cercosporin"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Fig. 2Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Fig. 2 MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "Fig. 2 MlcE, a putative efflux pump from the P. citrinum ",
                    "postfix": " biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "cercosporin",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the ",
                    "postfix": " facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cercosporin"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Fig. 2Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Fig. 2 Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Fig. 2 Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Phylogenetic clustering of putative ",
                    "postfix": " efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "Investigation of the potential of MlcE to confer the resistance to ",
                    "postfix": " in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The resulting strain ARX3 was tested for its susceptibility to ",
                    "postfix": ", MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The mlcE-expressing strain showed an increased resistance to ",
                    "postfix": " compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export ",
                    "postfix": " from yeast, and thereby increase the yeast's resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The resulting strain ARX3 was tested for its susceptibility to ",
                    "postfix": ", MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The mlcE-expressing strain showed an increased resistance to ",
                    "postfix": " compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export ",
                    "postfix": " from yeast, and thereby increase the yeast's resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The resulting strain ARX3 was tested for its susceptibility to ",
                    "postfix": ", MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The mlcE-expressing strain showed an increased resistance to ",
                    "postfix": " compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of ",
                    "postfix": " and simvastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin ",
                    "postfix": " and its semi-synthetic derivative simvastatin (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative ",
                    "postfix": " (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "atorvastatin",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, ",
                    "postfix": " or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                },
                {
                    "name": "vanillin",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds ",
                    "postfix": " and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "mycophenolic acid",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and ",
                    "postfix": " (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mycophenolic acid"
                },
                {
                    "name": "MPA",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (",
                    "postfix": ") (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                }
            ]
        },
        {
            "exact": "The specificity of MlcE and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The specificity of MlcE and its presence in the ",
                    "postfix": " biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of ",
                    "postfix": " and simvastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin ",
                    "postfix": " and its semi-synthetic derivative simvastatin (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative ",
                    "postfix": " (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "atorvastatin",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, ",
                    "postfix": " or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                },
                {
                    "name": "vanillin",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds ",
                    "postfix": " and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "mycophenolic acid",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and ",
                    "postfix": " (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mycophenolic acid"
                },
                {
                    "name": "MPA",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (",
                    "postfix": ") (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                }
            ]
        },
        {
            "exact": "The specificity of MlcE and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The specificity of MlcE and its presence in the ",
                    "postfix": " biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of ",
                    "postfix": " and simvastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin ",
                    "postfix": " and its semi-synthetic derivative simvastatin (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "simvastatin",
                    "prefix": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative ",
                    "postfix": " (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=simvastatin"
                }
            ]
        },
        {
            "exact": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "atorvastatin",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, ",
                    "postfix": " or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=atorvastatin"
                },
                {
                    "name": "vanillin",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds ",
                    "postfix": " and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=vanillin"
                },
                {
                    "name": "mycophenolic acid",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and ",
                    "postfix": " (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mycophenolic acid"
                },
                {
                    "name": "MPA",
                    "prefix": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (",
                    "postfix": ") (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MPA"
                }
            ]
        },
        {
            "exact": "The specificity of MlcE and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "The specificity of MlcE and its presence in the ",
                    "postfix": " biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory Statins are currently commercially produced by fermentation of natural statin-producing species of filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "MlcE and a future S. cerevisiae based ",
                    "postfix": " cell factory MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory Statins are currently commercially produced by fermentation of natural statin-producing species of filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statin-producing",
                    "prefix": "MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory Statins are currently commercially produced by fermentation of natural ",
                    "postfix": " species of filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of lovastatin (Jia et al., 2010) and 1200 mg/L (3.07 mM) of mevastatin (Choi et al., 2004), respectively.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of ",
                    "postfix": " (Jia et al., 2010) and 1200 mg/L (3.07 mM) of mevastatin (Choi et al., 2004), respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "mevastatin",
                    "prefix": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of lovastatin (Jia et al., 2010) and 1200 mg/L (3.07 mM) of ",
                    "postfix": " (Choi et al., 2004), respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "For future heterologous production of statins to be competitive, these titers will likely have to be matched and preferably exceeded.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "For future heterologous production of ",
                    "postfix": " to be competitive, these titers will likely have to be matched and preferably exceeded.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based ",
                    "postfix": " cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "dihydromonacolin L acid",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing ",
                    "postfix": " (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=dihydromonacolin L acid"
                },
                {
                    "name": "lovastatin",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the ",
                    "postfix": " pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "To test this, we cultured the reference wild type strain (WT) in liquid synthetic medium supplemented with increasing concentrations of activated lovastatin in a micro-fermentation setup.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "To test this, we cultured the reference wild type strain (WT) in liquid synthetic medium supplemented with increasing concentrations of activated ",
                    "postfix": " in a micro-fermentation setup.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "The analysis revealed that the IC50 value for extracellularly added lovastatin is approx.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The analysis revealed that the IC50 value for extracellularly added ",
                    "postfix": " is approx.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of ",
                    "postfix": " greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "lovas",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of ",
                    "postfix": "tatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovas"
                }
            ]
        },
        {
            "exact": "In the samples with 0 mM lovastatin, an equal volume of solvent was added.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "In the samples with 0 mM ",
                    "postfix": ", an equal volume of solvent was added.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of lovastatin (Jia et al., 2010) and 1200 mg/L (3.07 mM) of mevastatin (Choi et al., 2004), respectively.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of ",
                    "postfix": " (Jia et al., 2010) and 1200 mg/L (3.07 mM) of mevastatin (Choi et al., 2004), respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "mevastatin",
                    "prefix": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of lovastatin (Jia et al., 2010) and 1200 mg/L (3.07 mM) of ",
                    "postfix": " (Choi et al., 2004), respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "For future heterologous production of statins to be competitive, these titers will likely have to be matched and preferably exceeded.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "For future heterologous production of ",
                    "postfix": " to be competitive, these titers will likely have to be matched and preferably exceeded.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based ",
                    "postfix": " cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "dihydromonacolin L acid",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing ",
                    "postfix": " (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=dihydromonacolin L acid"
                },
                {
                    "name": "lovastatin",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the ",
                    "postfix": " pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "To test this, we cultured the reference wild type strain (WT) in liquid synthetic medium supplemented with increasing concentrations of activated lovastatin in a micro-fermentation setup.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "To test this, we cultured the reference wild type strain (WT) in liquid synthetic medium supplemented with increasing concentrations of activated ",
                    "postfix": " in a micro-fermentation setup.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "The analysis revealed that the IC50 value for extracellularly added lovastatin is approx.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The analysis revealed that the IC50 value for extracellularly added ",
                    "postfix": " is approx.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of ",
                    "postfix": " greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "lovas",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of ",
                    "postfix": "tatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovas"
                }
            ]
        },
        {
            "exact": "In the samples with 0 mM lovastatin, an equal volume of solvent was added.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "In the samples with 0 mM ",
                    "postfix": ", an equal volume of solvent was added.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of lovastatin (Jia et al., 2010) and 1200 mg/L (3.07 mM) of mevastatin (Choi et al., 2004), respectively.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of ",
                    "postfix": " (Jia et al., 2010) and 1200 mg/L (3.07 mM) of mevastatin (Choi et al., 2004), respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "mevastatin",
                    "prefix": "The highest titers reported for these systems have been achieved by submerged cultivation, reaching levels up to 950 mg/L (2.35 mM) of lovastatin (Jia et al., 2010) and 1200 mg/L (3.07 mM) of ",
                    "postfix": " (Choi et al., 2004), respectively.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "For future heterologous production of statins to be competitive, these titers will likely have to be matched and preferably exceeded.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statins",
                    "prefix": "For future heterologous production of ",
                    "postfix": " to be competitive, these titers will likely have to be matched and preferably exceeded.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statins"
                }
            ]
        },
        {
            "exact": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based ",
                    "postfix": " cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "dihydromonacolin L acid",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing ",
                    "postfix": " (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=dihydromonacolin L acid"
                },
                {
                    "name": "lovastatin",
                    "prefix": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the ",
                    "postfix": " pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "To test this, we cultured the reference wild type strain (WT) in liquid synthetic medium supplemented with increasing concentrations of activated lovastatin in a micro-fermentation setup.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "To test this, we cultured the reference wild type strain (WT) in liquid synthetic medium supplemented with increasing concentrations of activated ",
                    "postfix": " in a micro-fermentation setup.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "The analysis revealed that the IC50 value for extracellularly added lovastatin is approx.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The analysis revealed that the IC50 value for extracellularly added ",
                    "postfix": " is approx.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of ",
                    "postfix": " greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                },
                {
                    "name": "lovas",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of ",
                    "postfix": "tatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovas"
                }
            ]
        },
        {
            "exact": "In the samples with 0 mM lovastatin, an equal volume of solvent was added.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "In the samples with 0 mM ",
                    "postfix": ", an equal volume of solvent was added.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "In the samples with 0 mM lovastatin, an equal volume of solvent was added.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "In the samples with 0 mM ",
                    "postfix": ", an equal volume of solvent was added.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "In the samples with 0 mM lovastatin, an equal volume of solvent was added.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "In the samples with 0 mM ",
                    "postfix": ", an equal volume of solvent was added.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "In the samples with 0 mM lovastatin, an equal volume of solvent was added.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "In the samples with 0 mM ",
                    "postfix": ", an equal volume of solvent was added.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Lovastatin concentration (mM) Growth rate (h−1) Growth efficiency.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "",
                    "postfix": " concentration (mM) Growth rate (h−1) Growth efficiency.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "Lovastatin concentration (mM) Growth rate (h−1) Growth efficiency.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "",
                    "postfix": " concentration (mM) Growth rate (h−1) Growth efficiency.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "Lovastatin concentration (mM) Growth rate (h−1) Growth efficiency.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "Lovastatin",
                    "prefix": "",
                    "postfix": " concentration (mM) Growth rate (h−1) Growth efficiency.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Lovastatin"
                }
            ]
        },
        {
            "exact": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast ",
                    "postfix": " cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statin-producing",
                    "prefix": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for ",
                    "postfix": " filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at ",
                    "postfix": " concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast ",
                    "postfix": " cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statin-producing",
                    "prefix": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for ",
                    "postfix": " filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at ",
                    "postfix": " concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast ",
                    "postfix": " cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                },
                {
                    "name": "statin-producing",
                    "prefix": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for ",
                    "postfix": " filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin-producing"
                }
            ]
        },
        {
            "exact": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "lovastatin",
                    "prefix": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at ",
                    "postfix": " concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovastatin"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae ",
                    "postfix": " cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae ",
                    "postfix": " cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "statin",
                    "prefix": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae ",
                    "postfix": " cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=statin"
                }
            ]
        },
        {
            "exact": "Conclusions Conclusions We provide evidence that mlcE from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "Conclusions Conclusions We provide evidence that mlcE from the P. citrinum ",
                    "postfix": " biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "We provide evidence that mlcE from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-compound",
            "tags": [
                {
                    "name": "mevastatin",
                    "prefix": "We provide evidence that mlcE from the P. citrinum ",
                    "postfix": " biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mevastatin"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Ten-fold dilution series of WT (CEN.",
                    "postfix": " 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.",
                    "postfix": " 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-class",
            "tags": [
                {
                    "name": "PK",
                    "prefix": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.",
                    "postfix": " 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=PK"
                }
            ]
        },
        {
            "exact": "Expression of RFP-tagged mlcE showed that MlcE is localized to the yeast plasma and vacuolar membranes.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Expression of RFP-tagged mlcE showed that ",
                    "postfix": " is localized to the yeast plasma and vacuolar membranes.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•",
                    "postfix": " is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "MlcE is a transmembrane protein that localizes to the yeast plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "",
                    "postfix": " is a transmembrane protein that localizes to the yeast plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "MlcE significantly increases the yeast resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "",
                    "postfix": " significantly increases the yeast resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "In this study, we investigate the function of the putative efflux pump ",
                    "postfix": " from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "In this study, we investigate the function of the putative efflux pump ",
                    "postfix": " from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The subcellular localization of MlcE was determined by tagging it C-terminally with monomeric red fluorescent protein (RFP).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The subcellular localization of ",
                    "postfix": " was determined by tagging it C-terminally with monomeric red fluorescent protein (RFP).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The subcellular localization of MlcE was determined by tagging it C-terminally with monomeric red fluorescent protein (RFP).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The subcellular localization of ",
                    "postfix": " was determined by tagging it C-terminally with monomeric red fluorescent protein (RFP).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The subcellular localization of MlcE was determined by tagging it C-terminally with monomeric red fluorescent protein (RFP).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The subcellular localization of ",
                    "postfix": " was determined by tagging it C-terminally with monomeric red fluorescent protein (RFP).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "ARX1 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX1 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "ARX1 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX1 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "ARX1 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX1 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "Tcyc1",
                    "prefix": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-",
                    "postfix": " This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Tcyc1"
                }
            ]
        },
        {
            "exact": "Triplicate OD600 measurements were taken every 5 min for 24 h. Results and discussion Results and discussion Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Triplicate OD600 measurements were taken every 5 min for 24 h. Results and discussion Results and discussion Topology prediction and phylogenetic clustering of ",
                    "postfix": " Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MlcE MlcE",
                    "prefix": "Triplicate OD600 measurements were taken every 5 min for 24 h. Results and discussion Results and discussion Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of ",
                    "postfix": ", a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE MlcE"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The performed phylogenetic analysis showed that ",
                    "postfix": ", as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "LovI",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as ",
                    "postfix": " and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                },
                {
                    "name": "MokI",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and ",
                    "postfix": " (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                }
            ]
        },
        {
            "exact": "This classification is supported by the performed topology prediction, which showed that MlcE comprises of 14 TMS (data not shown), indicating that it is indeed a member of 14-TMS family.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This classification is supported by the performed topology prediction, which showed that ",
                    "postfix": " comprises of 14 TMS (data not shown), indicating that it is indeed a member of 14-TMS family.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "We next performed an in silico prediction of MlcE's subcellular localization, using CELLO v.2.5 to see where in eukaryotic cells the protein would be localized.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "We next performed an in silico prediction of ",
                    "postfix": "'s subcellular localization, using CELLO v.2.5 to see where in eukaryotic cells the protein would be localized.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Collectively, this proposes that MlcE is likely localized in the plasma membrane and functions as a statin efflux pump driven by the proton gradient found across the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Collectively, this proposes that ",
                    "postfix": " is likely localized in the plasma membrane and functions as a statin efflux pump driven by the proton gradient found across the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Fig. 2 MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2 ",
                    "postfix": ", a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The performed phylogenetic analysis showed that ",
                    "postfix": ", as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "LovI",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as ",
                    "postfix": " and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                },
                {
                    "name": "MokI",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and ",
                    "postfix": " (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                }
            ]
        },
        {
            "exact": "This classification is supported by the performed topology prediction, which showed that MlcE comprises of 14 TMS (data not shown), indicating that it is indeed a member of 14-TMS family.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This classification is supported by the performed topology prediction, which showed that ",
                    "postfix": " comprises of 14 TMS (data not shown), indicating that it is indeed a member of 14-TMS family.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "We next performed an in silico prediction of MlcE's subcellular localization, using CELLO v.2.5 to see where in eukaryotic cells the protein would be localized.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "We next performed an in silico prediction of ",
                    "postfix": "'s subcellular localization, using CELLO v.2.5 to see where in eukaryotic cells the protein would be localized.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Collectively, this proposes that MlcE is likely localized in the plasma membrane and functions as a statin efflux pump driven by the proton gradient found across the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Collectively, this proposes that ",
                    "postfix": " is likely localized in the plasma membrane and functions as a statin efflux pump driven by the proton gradient found across the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Fig. 2 MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2 ",
                    "postfix": ", a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The performed phylogenetic analysis showed that ",
                    "postfix": ", as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "LovI",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as ",
                    "postfix": " and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                },
                {
                    "name": "MokI",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and ",
                    "postfix": " (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                }
            ]
        },
        {
            "exact": "This classification is supported by the performed topology prediction, which showed that MlcE comprises of 14 TMS (data not shown), indicating that it is indeed a member of 14-TMS family.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This classification is supported by the performed topology prediction, which showed that ",
                    "postfix": " comprises of 14 TMS (data not shown), indicating that it is indeed a member of 14-TMS family.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "We next performed an in silico prediction of MlcE's subcellular localization, using CELLO v.2.5 to see where in eukaryotic cells the protein would be localized.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "We next performed an in silico prediction of ",
                    "postfix": "'s subcellular localization, using CELLO v.2.5 to see where in eukaryotic cells the protein would be localized.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Collectively, this proposes that MlcE is likely localized in the plasma membrane and functions as a statin efflux pump driven by the proton gradient found across the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Collectively, this proposes that ",
                    "postfix": " is likely localized in the plasma membrane and functions as a statin efflux pump driven by the proton gradient found across the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Fig. 2 Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 2 Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Fig. 2 Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Fig. 2 Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Phylogenetic clustering of putative statin efflux pumps (",
                    "postfix": ", MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                },
                {
                    "name": "MokI",
                    "prefix": "Phylogenetic clustering of putative statin efflux pumps (MlcE, ",
                    "postfix": " and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MokI"
                },
                {
                    "name": "LovI",
                    "prefix": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and ",
                    "postfix": ") with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=LovI"
                }
            ]
        },
        {
            "exact": "Subcellular localization of MlcE Subcellular localization of MlcE Subcellular localization of MlcE To experimentally determine the subcellular localization of MlcE in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Subcellular localization of ",
                    "postfix": " Subcellular localization of MlcE Subcellular localization of MlcE To experimentally determine the subcellular localization of MlcE in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fluorescent microscopy of the resulting strain, ARX1, revealed a ring-like distribution of the fluorescent protein at the periphery of the cells and inside the vacuole (Fig. 3B), indicating that the RFP-tagged MlcE was localized to the plasma and vacuolar membranes.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fluorescent microscopy of the resulting strain, ARX1, revealed a ring-like distribution of the fluorescent protein at the periphery of the cells and inside the vacuole (Fig. 3B), indicating that the RFP-tagged ",
                    "postfix": " was localized to the plasma and vacuolar membranes.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This subcellular localization of MlcE in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This subcellular localization of ",
                    "postfix": " in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 3Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "3 To experimentally determine the subcellular localization of MlcE in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "3 To experimentally determine the subcellular localization of ",
                    "postfix": " in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fluorescent microscopy of the resulting strain, ARX1, revealed a ring-like distribution of the fluorescent protein at the periphery of the cells and inside the vacuole (Fig. 3B), indicating that the RFP-tagged MlcE was localized to the plasma and vacuolar membranes.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fluorescent microscopy of the resulting strain, ARX1, revealed a ring-like distribution of the fluorescent protein at the periphery of the cells and inside the vacuole (Fig. 3B), indicating that the RFP-tagged ",
                    "postfix": " was localized to the plasma and vacuolar membranes.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This subcellular localization of MlcE in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This subcellular localization of ",
                    "postfix": " in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 3Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "3 To experimentally determine the subcellular localization of MlcE in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "3 To experimentally determine the subcellular localization of ",
                    "postfix": " in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fluorescent microscopy of the resulting strain, ARX1, revealed a ring-like distribution of the fluorescent protein at the periphery of the cells and inside the vacuole (Fig. 3B), indicating that the RFP-tagged MlcE was localized to the plasma and vacuolar membranes.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fluorescent microscopy of the resulting strain, ARX1, revealed a ring-like distribution of the fluorescent protein at the periphery of the cells and inside the vacuole (Fig. 3B), indicating that the RFP-tagged ",
                    "postfix": " was localized to the plasma and vacuolar membranes.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This subcellular localization of MlcE in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This subcellular localization of ",
                    "postfix": " in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Fig. 3Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "3 Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "3 Fig. 3Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "3 Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "3 Fig. 3Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "3 Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "3 Fig. 3Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "3 Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "3 Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Subcellular localization of ",
                    "postfix": " in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, ",
                    "postfix": "'s predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4 We next tested if the localization of ",
                    "postfix": " to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, ",
                    "postfix": "'s predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4 We next tested if the localization of ",
                    "postfix": " to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, MlcE's predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The resulting strain ARX3 was tested for its susceptibility to mevastatin, ",
                    "postfix": "'s predicted natural substrate, by serial dilution plating on YPD agar plates supplemented with the active form of mevastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4 Fig. 4Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4 Fig. 4Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4 Fig. 4Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "4 Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "4 Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Investigation of the potential of ",
                    "postfix": " to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring ",
                    "postfix": " efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To determine if ",
                    "postfix": " would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This shows that MlcE is able to accept not only its native substrate but also structurally related natural compounds, and even compounds it has not encountered during evolution, when expressed in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This shows that ",
                    "postfix": " is able to accept not only its native substrate but also structurally related natural compounds, and even compounds it has not encountered during evolution, when expressed in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To determine whether ",
                    "postfix": " should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This analysis showed that ",
                    "postfix": " was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "These results suggest that MlcE is not a multi-drug resistance efflux pump.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "These results suggest that ",
                    "postfix": " is not a multi-drug resistance efflux pump.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The specificity of MlcE and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The specificity of ",
                    "postfix": " and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To determine if ",
                    "postfix": " would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This shows that MlcE is able to accept not only its native substrate but also structurally related natural compounds, and even compounds it has not encountered during evolution, when expressed in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This shows that ",
                    "postfix": " is able to accept not only its native substrate but also structurally related natural compounds, and even compounds it has not encountered during evolution, when expressed in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To determine whether ",
                    "postfix": " should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This analysis showed that ",
                    "postfix": " was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "These results suggest that MlcE is not a multi-drug resistance efflux pump.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "These results suggest that ",
                    "postfix": " is not a multi-drug resistance efflux pump.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The specificity of MlcE and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The specificity of ",
                    "postfix": " and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To determine if MlcE would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To determine if ",
                    "postfix": " would be able to excrete other structurally related compounds, we tested the effects of lovastatin and simvastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This shows that MlcE is able to accept not only its native substrate but also structurally related natural compounds, and even compounds it has not encountered during evolution, when expressed in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This shows that ",
                    "postfix": " is able to accept not only its native substrate but also structurally related natural compounds, and even compounds it has not encountered during evolution, when expressed in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To determine whether ",
                    "postfix": " should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "This analysis showed that MlcE was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "This analysis showed that ",
                    "postfix": " was not able to protect yeast against the lethal effects of the synthetic statin, atorvastatin or the effects of the natural compounds vanillin and mycophenolic acid (MPA) (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "These results suggest that MlcE is not a multi-drug resistance efflux pump.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "These results suggest that ",
                    "postfix": " is not a multi-drug resistance efflux pump.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "The specificity of MlcE and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "The specificity of ",
                    "postfix": " and its presence in the mevastatin biosynthetic gene cluster suggest that it has likely evolved as a statin efflux pump; however, testing in the endogenous species is still required to confirm this.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory Statins are currently commercially produced by fermentation of natural statin-producing species of filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "",
                    "postfix": " and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory Statins are currently commercially produced by fermentation of natural statin-producing species of filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "For this, MlcE constitutes a potential tool for tackling the described self-intoxication problem.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "For this, ",
                    "postfix": " constitutes a potential tool for tackling the described self-intoxication problem.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To investigate if it would also provide protection from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To investigate if it would also provide protection from statins in liquid cultures, the ",
                    "postfix": " expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "For this, MlcE constitutes a potential tool for tackling the described self-intoxication problem.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "For this, ",
                    "postfix": " constitutes a potential tool for tackling the described self-intoxication problem.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To investigate if it would also provide protection from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To investigate if it would also provide protection from statins in liquid cultures, the ",
                    "postfix": " expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "For this, MlcE constitutes a potential tool for tackling the described self-intoxication problem.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "For this, ",
                    "postfix": " constitutes a potential tool for tackling the described self-intoxication problem.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "To investigate if it would also provide protection from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "To investigate if it would also provide protection from statins in liquid cultures, the ",
                    "postfix": " expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Direct proof of the effects of implementing the ",
                    "postfix": " based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Direct proof of the effects of implementing the ",
                    "postfix": " based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Direct proof of the effects of implementing the ",
                    "postfix": " based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Moreover, MlcE significantly increases yeast resistance to both, natural and semi-synthetic statins, likely by exporting the compounds from the cells.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Moreover, ",
                    "postfix": " significantly increases yeast resistance to both, natural and semi-synthetic statins, likely by exporting the compounds from the cells.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Moreover, MlcE significantly increases yeast resistance to both, natural and semi-synthetic statins, likely by exporting the compounds from the cells.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-product-name",
            "tags": [
                {
                    "name": "MlcE",
                    "prefix": "Moreover, ",
                    "postfix": " significantly increases yeast resistance to both, natural and semi-synthetic statins, likely by exporting the compounds from the cells.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=MlcE"
                }
            ]
        },
        {
            "exact": "Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the key enzyme in cholesterol biosynthesis.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "inhibitors",
                    "prefix": "Statins are ",
                    "postfix": " of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the key enzyme in cholesterol biosynthesis.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=inhibitors"
                }
            ]
        },
        {
            "exact": "Their extensive use in treatment and prevention of cardiovascular diseases placed statins among the best selling drugs.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "treatment",
                    "prefix": "Their extensive use in ",
                    "postfix": " and prevention of cardiovascular diseases placed statins among the best selling drugs.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=treatment"
                },
                {
                    "name": "prevention of cardiovascular diseases",
                    "prefix": "Their extensive use in treatment and ",
                    "postfix": " placed statins among the best selling drugs.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=prevention of cardiovascular diseases"
                }
            ]
        },
        {
            "exact": "Construction of Saccharomyces cerevisiae cell factory for the production of high concentrations of natural statins will require establishment of a non-destructive self-resistance mechanism to overcome the undesirable growth inhibition effects of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-resistance",
                    "prefix": "Construction of Saccharomyces cerevisiae cell factory for the production of high concentrations of natural statins will require establishment of a non-destructive ",
                    "postfix": " mechanism to overcome the undesirable growth inhibition effects of statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-resistance"
                },
                {
                    "name": "growth inhibition",
                    "prefix": "Construction of Saccharomyces cerevisiae cell factory for the production of high concentrations of natural statins will require establishment of a non-destructive self-resistance mechanism to overcome the undesirable ",
                    "postfix": " effects of statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=growth inhibition"
                }
            ]
        },
        {
            "exact": "The resulting strain showed increased resistance to both natural statins (mevastatin and lovastatin) and semi-synthetic statin (simvastatin) when compared to the wild type strain.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "The resulting strain showed increased ",
                    "postfix": " to both natural statins (mevastatin and lovastatin) and semi-synthetic statin (simvastatin) when compared to the wild type strain.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Highlights •Yeast-based cell factory for statin production will require a ",
                    "postfix": " mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Yeast-based cell factory for statin production will require a resistance mechanism.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Yeast-based cell factory for statin production will require a ",
                    "postfix": " mechanism.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "MlcE significantly increases the yeast resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "MlcE significantly increases the yeast ",
                    "postfix": " to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Keywords Introduction Introduction Statins are used as cholesterol-lowering drugs in treatment and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cholesterol-lowering",
                    "prefix": "Keywords Introduction Introduction Statins are used as ",
                    "postfix": " drugs in treatment and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cholesterol-lowering"
                },
                {
                    "name": "treatment",
                    "prefix": "Keywords Introduction Introduction Statins are used as cholesterol-lowering drugs in ",
                    "postfix": " and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=treatment"
                },
                {
                    "name": "treatment and prevention of coronary heart diseases",
                    "prefix": "Keywords Introduction Introduction Statins are used as cholesterol-lowering drugs in ",
                    "postfix": ", and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=treatment and prevention of coronary heart diseases"
                }
            ]
        },
        {
            "exact": "It will, however be crucial to establish a nondestructive resistance mechanism in yeast to overcome the undesirable growth inhibition effects of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "It will, however be crucial to establish a nondestructive ",
                    "postfix": " mechanism in yeast to overcome the undesirable growth inhibition effects of statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                },
                {
                    "name": "growth inhibition",
                    "prefix": "It will, however be crucial to establish a nondestructive resistance mechanism in yeast to overcome the undesirable ",
                    "postfix": " effects of statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=growth inhibition"
                }
            ]
        },
        {
            "exact": "Export systems have previously proved to be efficient in increasing the tolerance of microorganisms to the produced compounds, either relying on native efflux pumps, as it has been shown for the production of several antibiotics (Malla et al., 2010, Ullán et al., 2002, Xu et al., 2012), or via heterologous pumps as shown in Escherichia coli in connection with biofuel synthesis (Dunlop et al., 2011).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "antibiotics",
                    "prefix": "Export systems have previously proved to be efficient in increasing the tolerance of microorganisms to the produced compounds, either relying on native efflux pumps, as it has been shown for the production of several ",
                    "postfix": " (Malla et al., 2010, Ullán et al., 2002, Xu et al., 2012), or via heterologous pumps as shown in Escherichia coli in connection with biofuel synthesis (Dunlop et al., 2011).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=antibiotics"
                }
            ]
        },
        {
            "exact": "Fig. 1 Statins are used as cholesterol-lowering drugs in treatment and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cholesterol-lowering",
                    "prefix": "Fig. 1 Statins are used as ",
                    "postfix": " drugs in treatment and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cholesterol-lowering"
                },
                {
                    "name": "treatment",
                    "prefix": "Fig. 1 Statins are used as cholesterol-lowering drugs in ",
                    "postfix": " and prevention of coronary heart diseases, and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=treatment"
                },
                {
                    "name": "treatment and prevention of coronary heart diseases",
                    "prefix": "Fig. 1 Statins are used as cholesterol-lowering drugs in ",
                    "postfix": ", and their extensive worldwide usage placed them among the best selling pharmaceuticals in the past decade (GBI Research, 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=treatment and prevention of coronary heart diseases"
                }
            ]
        },
        {
            "exact": "It will, however be crucial to establish a nondestructive resistance mechanism in yeast to overcome the undesirable growth inhibition effects of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "It will, however be crucial to establish a nondestructive ",
                    "postfix": " mechanism in yeast to overcome the undesirable growth inhibition effects of statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                },
                {
                    "name": "growth inhibition",
                    "prefix": "It will, however be crucial to establish a nondestructive resistance mechanism in yeast to overcome the undesirable ",
                    "postfix": " effects of statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=growth inhibition"
                }
            ]
        },
        {
            "exact": "Export systems have previously proved to be efficient in increasing the tolerance of microorganisms to the produced compounds, either relying on native efflux pumps, as it has been shown for the production of several antibiotics (Malla et al., 2010, Ullán et al., 2002, Xu et al., 2012), or via heterologous pumps as shown in Escherichia coli in connection with biofuel synthesis (Dunlop et al., 2011).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "antibiotics",
                    "prefix": "Export systems have previously proved to be efficient in increasing the tolerance of microorganisms to the produced compounds, either relying on native efflux pumps, as it has been shown for the production of several ",
                    "postfix": " (Malla et al., 2010, Ullán et al., 2002, Xu et al., 2012), or via heterologous pumps as shown in Escherichia coli in connection with biofuel synthesis (Dunlop et al., 2011).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=antibiotics"
                }
            ]
        },
        {
            "exact": "Secondary metabolite gene clusters, in addition to the catalytic enzymes, often encode proteins for secretion of the produced bioactive compounds and thereby also a self-resistance mechanism (reviewed in Martín et al., 2005).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-resistance",
                    "prefix": "Secondary metabolite gene clusters, in addition to the catalytic enzymes, often encode proteins for secretion of the produced bioactive compounds and thereby also a ",
                    "postfix": " mechanism (reviewed in Martín et al., 2005).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-resistance"
                }
            ]
        },
        {
            "exact": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin ",
                    "postfix": " (unpublished result in Hutchinson et al., 2000).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-resistance",
                    "prefix": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary ",
                    "postfix": " mechanism for the production of statins in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-resistance"
                }
            ]
        },
        {
            "exact": "Secondary metabolite gene clusters, in addition to the catalytic enzymes, often encode proteins for secretion of the produced bioactive compounds and thereby also a self-resistance mechanism (reviewed in Martín et al., 2005).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-resistance",
                    "prefix": "Secondary metabolite gene clusters, in addition to the catalytic enzymes, often encode proteins for secretion of the produced bioactive compounds and thereby also a ",
                    "postfix": " mechanism (reviewed in Martín et al., 2005).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-resistance"
                }
            ]
        },
        {
            "exact": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin ",
                    "postfix": " (unpublished result in Hutchinson et al., 2000).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-resistance",
                    "prefix": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary ",
                    "postfix": " mechanism for the production of statins in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-resistance"
                }
            ]
        },
        {
            "exact": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin ",
                    "postfix": " in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin ",
                    "postfix": " in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "4.5 µL of each dilution were plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "4.5 µL of each dilution were plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "4.5 µL of each dilution were plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "4.5 µL of each dilution were plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "4.5 µL of each dilution were plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "4.5 µL of each dilution were plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxin",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-",
                    "postfix": " efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxin"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxin",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-",
                    "postfix": " efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxin"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-toxin efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxin",
                    "prefix": "The performed phylogenetic analysis showed that MlcE, as well as LovI and MokI (Fig. 2), clustered with known members of 14-TMS family of drug resistance proteins, such as the cercosporin facilitator protein (CFP) from Cercospora kikuchii (Callahan et al., 1999) and HC-",
                    "postfix": " efflux pump (ToxA) from Cochliobolus carbonum (Pitkin et al., 1996) (further proteins are listed in Supplementary Table S1).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxin"
                }
            ]
        },
        {
            "exact": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Fig. 2 Fig. 2Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "Fig. 2 Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Fig. 2 Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of toxic compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "Phylogenetic clustering of putative statin efflux pumps (MlcE, MokI and LovI) with major facilitator superfamily (MFS) transporters involved in the efflux of ",
                    "postfix": " compounds, belonging to the subfamily of proteins with 14 transmembrane domains (14-TMS family).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "The mlcE-expressing strain showed an increased ",
                    "postfix": " to mevastatin compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's ",
                    "postfix": " to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "The mlcE-expressing strain showed an increased ",
                    "postfix": " to mevastatin compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4 We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's ",
                    "postfix": " to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "The mlcE-expressing strain showed an increased ",
                    "postfix": " to mevastatin compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4 Fig. 4Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4 Fig. 4Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4 Fig. 4Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "4 Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "4 Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Investigation of the potential of MlcE to confer the ",
                    "postfix": " to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different cytotoxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "cytotoxic",
                    "prefix": "Ten-fold dilution series of WT (CEN.PK 113-11C) and ARX3 strains (harboring MlcE efflux pump), starting with and OD600 of 0.02 were prepared from overnight cultures and plated on a set of YPD agar plates containing different ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=cytotoxic"
                }
            ]
        },
        {
            "exact": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other toxic compounds.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "toxic",
                    "prefix": "To determine whether MlcE should be considered as a general pleiotropic efflux pump, or a dedicated statin pump, we tested the susceptibility of the ARX3 strain to other ",
                    "postfix": " compounds.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=toxic"
                }
            ]
        },
        {
            "exact": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-resistance",
                    "prefix": "These results show the necessity of establishing a non-destructive ",
                    "postfix": " mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-resistance"
                }
            ]
        },
        {
            "exact": "For this, MlcE constitutes a potential tool for tackling the described self-intoxication problem.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-intoxication",
                    "prefix": "For this, MlcE constitutes a potential tool for tackling the described ",
                    "postfix": " problem.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-intoxication"
                }
            ]
        },
        {
            "exact": "To investigate if it would also provide protection from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "protection",
                    "prefix": "To investigate if it would also provide ",
                    "postfix": " from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=protection"
                }
            ]
        },
        {
            "exact": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-resistance",
                    "prefix": "These results show the necessity of establishing a non-destructive ",
                    "postfix": " mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-resistance"
                }
            ]
        },
        {
            "exact": "For this, MlcE constitutes a potential tool for tackling the described self-intoxication problem.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-intoxication",
                    "prefix": "For this, MlcE constitutes a potential tool for tackling the described ",
                    "postfix": " problem.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-intoxication"
                }
            ]
        },
        {
            "exact": "To investigate if it would also provide protection from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "protection",
                    "prefix": "To investigate if it would also provide ",
                    "postfix": " from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=protection"
                }
            ]
        },
        {
            "exact": "These results show the necessity of establishing a non-destructive self-resistance mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-resistance",
                    "prefix": "These results show the necessity of establishing a non-destructive ",
                    "postfix": " mechanism in a future yeast statin cell factory to allow for titers similar to those reported for statin-producing filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-resistance"
                }
            ]
        },
        {
            "exact": "For this, MlcE constitutes a potential tool for tackling the described self-intoxication problem.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "self-intoxication",
                    "prefix": "For this, MlcE constitutes a potential tool for tackling the described ",
                    "postfix": " problem.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=self-intoxication"
                }
            ]
        },
        {
            "exact": "To investigate if it would also provide protection from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "protection",
                    "prefix": "To investigate if it would also provide ",
                    "postfix": " from statins in liquid cultures, the MlcE expressing strain (ARX3) was tested as described above for the reference wild type strain (Table 2).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=protection"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Direct proof of the effects of implementing the MlcE based ",
                    "postfix": " in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "However, implementation could likely have additional benefits such as increasing titers by reducing feedback inhibition of the pathway enzymes caused by high intracellular concentrations of statins and furthermore reduce product purification costs.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "inhibition",
                    "prefix": "However, implementation could likely have additional benefits such as increasing titers by reducing feedback ",
                    "postfix": " of the pathway enzymes caused by high intracellular concentrations of statins and furthermore reduce product purification costs.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=inhibition"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Direct proof of the effects of implementing the MlcE based ",
                    "postfix": " in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "However, implementation could likely have additional benefits such as increasing titers by reducing feedback inhibition of the pathway enzymes caused by high intracellular concentrations of statins and furthermore reduce product purification costs.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "inhibition",
                    "prefix": "However, implementation could likely have additional benefits such as increasing titers by reducing feedback ",
                    "postfix": " of the pathway enzymes caused by high intracellular concentrations of statins and furthermore reduce product purification costs.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=inhibition"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Direct proof of the effects of implementing the MlcE based ",
                    "postfix": " in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "However, implementation could likely have additional benefits such as increasing titers by reducing feedback inhibition of the pathway enzymes caused by high intracellular concentrations of statins and furthermore reduce product purification costs.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "inhibition",
                    "prefix": "However, implementation could likely have additional benefits such as increasing titers by reducing feedback ",
                    "postfix": " of the pathway enzymes caused by high intracellular concentrations of statins and furthermore reduce product purification costs.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=inhibition"
                }
            ]
        },
        {
            "exact": "Moreover, MlcE significantly increases yeast resistance to both, natural and semi-synthetic statins, likely by exporting the compounds from the cells.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Moreover, MlcE significantly increases yeast ",
                    "postfix": " to both, natural and semi-synthetic statins, likely by exporting the compounds from the cells.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "This resistance mechanism has a potential to improve future yeast based production of natural and semi-synthetic statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "This ",
                    "postfix": " mechanism has a potential to improve future yeast based production of natural and semi-synthetic statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "Moreover, MlcE significantly increases yeast resistance to both, natural and semi-synthetic statins, likely by exporting the compounds from the cells.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "Moreover, MlcE significantly increases yeast ",
                    "postfix": " to both, natural and semi-synthetic statins, likely by exporting the compounds from the cells.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "This resistance mechanism has a potential to improve future yeast based production of natural and semi-synthetic statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-action",
            "tags": [
                {
                    "name": "resistance",
                    "prefix": "This ",
                    "postfix": " mechanism has a potential to improve future yeast based production of natural and semi-synthetic statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=resistance"
                }
            ]
        },
        {
            "exact": "To establish active export of statins from yeast, and thereby detoxification, we integrated a putative efflux pump-encoding gene mlcE from the mevastatin-producing Penicillium citrinum into the S. cerevisiae genome.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "To establish active export of statins from yeast, and thereby detoxification, we integrated a putative efflux pump-encoding gene ",
                    "postfix": " from the mevastatin-producing Penicillium citrinum into the S. cerevisiae genome.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "Expression of RFP-tagged mlcE showed that MlcE is localized to the yeast plasma and vacuolar membranes.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "Expression of RFP-tagged ",
                    "postfix": " showed that MlcE is localized to the yeast plasma and vacuolar membranes.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump ",
                    "postfix": " from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "We expressed putative efflux pump ",
                    "postfix": " from P. citrinum in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mok",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (",
                    "postfix": " genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mok"
                },
                {
                    "name": "lov",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (",
                    "postfix": " genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lov"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mok",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (",
                    "postfix": " genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mok"
                },
                {
                    "name": "lov",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (",
                    "postfix": " genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lov"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mok",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (",
                    "postfix": " genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mok"
                },
                {
                    "name": "lov",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (",
                    "postfix": " genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lov"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mok",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (",
                    "postfix": " genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mok"
                },
                {
                    "name": "lov",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (",
                    "postfix": " genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lov"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mok",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (",
                    "postfix": " genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mok"
                },
                {
                    "name": "lov",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (",
                    "postfix": " genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lov"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mok",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (",
                    "postfix": " genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mok"
                },
                {
                    "name": "lov",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (",
                    "postfix": " genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lov"
                }
            ]
        },
        {
            "exact": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; ",
                    "postfix": " in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "lovI",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and ",
                    "postfix": " or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovI"
                },
                {
                    "name": "mokI",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or ",
                    "postfix": " in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mokI"
                }
            ]
        },
        {
            "exact": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "lovI",
                    "prefix": "Hutchinson et al. found that A. terreus ",
                    "postfix": " mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovI"
                }
            ]
        },
        {
            "exact": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; ",
                    "postfix": " in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "lovI",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and ",
                    "postfix": " or mokI in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovI"
                },
                {
                    "name": "mokI",
                    "prefix": "This is also likely the case for the known statin clusters, where putative efflux pump encoding genes are present; mlcE in the mevastatin cluster (Fig. 1A) (Abe et al., 2002), and lovI or ",
                    "postfix": " in the lovastatin cluster of A. terreus (Kennedy et al., 1999) or M. ruber (Chen et al., 2008), respectively (Fig. 1B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mokI"
                }
            ]
        },
        {
            "exact": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "lovI",
                    "prefix": "Hutchinson et al. found that A. terreus ",
                    "postfix": " mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=lovI"
                }
            ]
        },
        {
            "exact": "Construction of plasmids and strains Construction of plasmids and strains Construction of plasmids and strains A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "Construction of plasmids and strains Construction of plasmids and strains Construction of plasmids and strains A yeast codon-optimized version of the ",
                    "postfix": " gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "mlcE-F",
                    "prefix": "Construction of plasmids and strains Construction of plasmids and strains Construction of plasmids and strains A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers ",
                    "postfix": " and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-F"
                },
                {
                    "name": "mlcE-R",
                    "prefix": "Construction of plasmids and strains Construction of plasmids and strains Construction of plasmids and strains A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and ",
                    "postfix": ". The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-R"
                }
            ]
        },
        {
            "exact": "For that plasmid pX3-TEF1-mlcE-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "For that plasmid pX3-TEF1-",
                    "postfix": "-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                },
                {
                    "name": "mlcE",
                    "prefix": "For that plasmid pX3-TEF1-",
                    "postfix": "-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "mlcE-F",
                    "prefix": "For that plasmid pX3-TEF1-mlcE-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair ",
                    "postfix": " and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-F"
                }
            ]
        },
        {
            "exact": "The URA3 markers in the constructed strains were removed by direct repeat recombination using 5-FOA (Melford) counter selection.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "URA3",
                    "prefix": "The ",
                    "postfix": " markers in the constructed strains were removed by direct repeat recombination using 5-FOA (Melford) counter selection.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=URA3"
                }
            ]
        },
        {
            "exact": "Table 1Primer namePrimer sequence (5′– 3′)UsemlcE-FAGCGATACGUAAAAATGAGTGAACCATTACCAmplification of mlcE from plasmid pEN669mlcE-RCACGCGAUTTATGCATCAGTCTCAGTEF1-dACGTATCGCUGTGAGTCGTATTACGGATCCTTGAmplification of promoter sequence from plasmid pSP-G2PGK1-sCGTGCGAUGCCGCTTGTTTTATATTTGTTGRFP_F+ATGGCCTCCUCCGAGGACGTCATCAAGGAGAmplification of RFP from plasmid pWJ1350RFP_R+CACGCGAUCTAGGCGCCGGTGGAGTGGCGGmlcE-RFP-RAGGAGGCCAUTGCATCAGTCTCAGGGACAmplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1RFP-FAGCGATACGUAAAAATGGCCTCCTCCGAGAmplification of RFP from plasmid pX3-TEF1-mlcE-RFP-CYC1X-3-up-out-sqTGACGAATCGTTAGGCACAGStrain confirmation via colony PCRC1_TADH1_FCTTGAGTAACTCTTTCCTGTAPlasmid nameDescriptionReference or sourcepEN669Template for amplifying mlcE (S. cerevisiae codon optimized)From Evolva Holding SApWJ1350Template for amplifying RFPLisby et al. (2003)pSP-G2Template for amplifying TEF1Partow et al. (2010)pX3USER cloning vector equipped with the CYC1 terminator designed to target site 3 on chromosome X.Mikkelsen et al. (2012)pX3-TEF1-mlcE-CYC1Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "Table 1Primer namePrimer sequence (5′– 3′)Use",
                    "postfix": "-FAGCGATACGUAAAAATGAGTGAACCATTACCAmplification of mlcE from plasmid pEN669mlcE-RCACGCGAUTTATGCATCAGTCTCAGTEF1-dACGTATCGCUGTGAGTCGTATTACGGATCCTTGAmplification of promoter sequence from plasmid pSP-G2PGK1-sCGTGCGAUGCCGCTTGTTTTATATTTGTTGRFP_F+ATGGCCTCCUCCGAGGACGTCATCAAGGAGAmplification of RFP from plasmid pWJ1350RFP_R+CACGCGAUCTAGGCGCCGGTGGAGTGGCGGmlcE-RFP-RAGGAGGCCAUTGCATCAGTCTCAGGGACAmplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1RFP-FAGCGATACGUAAAAATGGCCTCCTCCGAGAmplification of RFP from plasmid pX3-TEF1-mlcE-RFP-CYC1X-3-up-out-sqTGACGAATCGTTAGGCACAGStrain confirmation via colony PCRC1_TADH1_FCTTGAGTAACTCTTTCCTGTAPlasmid nameDescriptionReference or sourcepEN669Template for amplifying mlcE (S. cerevisiae codon optimized)From Evolva Holding SApWJ1350Template for amplifying RFPLisby et al. (2003)pSP-G2Template for amplifying TEF1Partow et al. (2010)pX3USER cloning vector equipped with the CYC1 terminator designed to target site 3 on chromosome X.Mikkelsen et al. (2012)pX3-TEF1-mlcE-CYC1Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "This studypX3-TEF1-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP-tagged mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "This studypX3-TEF1-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP-tagged ",
                    "postfix": " in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "This studypX3-TEF1-mlcE-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "This studypX3-TEF1-",
                    "postfix": "-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "recA1 endA1",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 ",
                    "postfix": " hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=recA1 endA1"
                },
                {
                    "name": "phoA supE44",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) ",
                    "postfix": " λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=phoA supE44"
                },
                {
                    "name": "relA1Woodcock",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 ",
                    "postfix": " et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=relA1Woodcock"
                }
            ]
        },
        {
            "exact": "For that plasmid pX3-TEF1-mlcE-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "For that plasmid pX3-TEF1-",
                    "postfix": "-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                },
                {
                    "name": "mlcE",
                    "prefix": "For that plasmid pX3-TEF1-",
                    "postfix": "-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "mlcE-F",
                    "prefix": "For that plasmid pX3-TEF1-mlcE-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair ",
                    "postfix": " and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-F"
                }
            ]
        },
        {
            "exact": "The URA3 markers in the constructed strains were removed by direct repeat recombination using 5-FOA (Melford) counter selection.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "URA3",
                    "prefix": "The ",
                    "postfix": " markers in the constructed strains were removed by direct repeat recombination using 5-FOA (Melford) counter selection.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=URA3"
                }
            ]
        },
        {
            "exact": "Table 1Primer namePrimer sequence (5′– 3′)UsemlcE-FAGCGATACGUAAAAATGAGTGAACCATTACCAmplification of mlcE from plasmid pEN669mlcE-RCACGCGAUTTATGCATCAGTCTCAGTEF1-dACGTATCGCUGTGAGTCGTATTACGGATCCTTGAmplification of promoter sequence from plasmid pSP-G2PGK1-sCGTGCGAUGCCGCTTGTTTTATATTTGTTGRFP_F+ATGGCCTCCUCCGAGGACGTCATCAAGGAGAmplification of RFP from plasmid pWJ1350RFP_R+CACGCGAUCTAGGCGCCGGTGGAGTGGCGGmlcE-RFP-RAGGAGGCCAUTGCATCAGTCTCAGGGACAmplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1RFP-FAGCGATACGUAAAAATGGCCTCCTCCGAGAmplification of RFP from plasmid pX3-TEF1-mlcE-RFP-CYC1X-3-up-out-sqTGACGAATCGTTAGGCACAGStrain confirmation via colony PCRC1_TADH1_FCTTGAGTAACTCTTTCCTGTAPlasmid nameDescriptionReference or sourcepEN669Template for amplifying mlcE (S. cerevisiae codon optimized)From Evolva Holding SApWJ1350Template for amplifying RFPLisby et al. (2003)pSP-G2Template for amplifying TEF1Partow et al. (2010)pX3USER cloning vector equipped with the CYC1 terminator designed to target site 3 on chromosome X.Mikkelsen et al. (2012)pX3-TEF1-mlcE-CYC1Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "Table 1Primer namePrimer sequence (5′– 3′)Use",
                    "postfix": "-FAGCGATACGUAAAAATGAGTGAACCATTACCAmplification of mlcE from plasmid pEN669mlcE-RCACGCGAUTTATGCATCAGTCTCAGTEF1-dACGTATCGCUGTGAGTCGTATTACGGATCCTTGAmplification of promoter sequence from plasmid pSP-G2PGK1-sCGTGCGAUGCCGCTTGTTTTATATTTGTTGRFP_F+ATGGCCTCCUCCGAGGACGTCATCAAGGAGAmplification of RFP from plasmid pWJ1350RFP_R+CACGCGAUCTAGGCGCCGGTGGAGTGGCGGmlcE-RFP-RAGGAGGCCAUTGCATCAGTCTCAGGGACAmplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1RFP-FAGCGATACGUAAAAATGGCCTCCTCCGAGAmplification of RFP from plasmid pX3-TEF1-mlcE-RFP-CYC1X-3-up-out-sqTGACGAATCGTTAGGCACAGStrain confirmation via colony PCRC1_TADH1_FCTTGAGTAACTCTTTCCTGTAPlasmid nameDescriptionReference or sourcepEN669Template for amplifying mlcE (S. cerevisiae codon optimized)From Evolva Holding SApWJ1350Template for amplifying RFPLisby et al. (2003)pSP-G2Template for amplifying TEF1Partow et al. (2010)pX3USER cloning vector equipped with the CYC1 terminator designed to target site 3 on chromosome X.Mikkelsen et al. (2012)pX3-TEF1-mlcE-CYC1Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "This studypX3-TEF1-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP-tagged mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "This studypX3-TEF1-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP-tagged ",
                    "postfix": " in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "This studypX3-TEF1-mlcE-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "This studypX3-TEF1-",
                    "postfix": "-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "recA1 endA1",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 ",
                    "postfix": " hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=recA1 endA1"
                },
                {
                    "name": "phoA supE44",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) ",
                    "postfix": " λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=phoA supE44"
                },
                {
                    "name": "relA1Woodcock",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 ",
                    "postfix": " et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=relA1Woodcock"
                }
            ]
        },
        {
            "exact": "For that plasmid pX3-TEF1-mlcE-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "For that plasmid pX3-TEF1-",
                    "postfix": "-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                },
                {
                    "name": "mlcE",
                    "prefix": "For that plasmid pX3-TEF1-",
                    "postfix": "-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair mlcE-F and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "mlcE-F",
                    "prefix": "For that plasmid pX3-TEF1-mlcE-RFP-CYC1 and a control plasmid pX3-TEF1-RFP-CYC1 were constructed as follows: the coding sequence of mlcE lacking the stop codon was amplified using the primer pair ",
                    "postfix": " and mlcE-RFP-R, and a yeast codon-optimized RFP was amplified from plasmid pWJ1350 (Lisby et al., 2003) using the primers RFP_R+ and either RFP-F (for tagging mlcE) or RFP_F+ (for the control plasmid).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-F"
                }
            ]
        },
        {
            "exact": "The URA3 markers in the constructed strains were removed by direct repeat recombination using 5-FOA (Melford) counter selection.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "URA3",
                    "prefix": "The ",
                    "postfix": " markers in the constructed strains were removed by direct repeat recombination using 5-FOA (Melford) counter selection.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=URA3"
                }
            ]
        },
        {
            "exact": "Table 1Primer namePrimer sequence (5′– 3′)UsemlcE-FAGCGATACGUAAAAATGAGTGAACCATTACCAmplification of mlcE from plasmid pEN669mlcE-RCACGCGAUTTATGCATCAGTCTCAGTEF1-dACGTATCGCUGTGAGTCGTATTACGGATCCTTGAmplification of promoter sequence from plasmid pSP-G2PGK1-sCGTGCGAUGCCGCTTGTTTTATATTTGTTGRFP_F+ATGGCCTCCUCCGAGGACGTCATCAAGGAGAmplification of RFP from plasmid pWJ1350RFP_R+CACGCGAUCTAGGCGCCGGTGGAGTGGCGGmlcE-RFP-RAGGAGGCCAUTGCATCAGTCTCAGGGACAmplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1RFP-FAGCGATACGUAAAAATGGCCTCCTCCGAGAmplification of RFP from plasmid pX3-TEF1-mlcE-RFP-CYC1X-3-up-out-sqTGACGAATCGTTAGGCACAGStrain confirmation via colony PCRC1_TADH1_FCTTGAGTAACTCTTTCCTGTAPlasmid nameDescriptionReference or sourcepEN669Template for amplifying mlcE (S. cerevisiae codon optimized)From Evolva Holding SApWJ1350Template for amplifying RFPLisby et al. (2003)pSP-G2Template for amplifying TEF1Partow et al. (2010)pX3USER cloning vector equipped with the CYC1 terminator designed to target site 3 on chromosome X.Mikkelsen et al. (2012)pX3-TEF1-mlcE-CYC1Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "Table 1Primer namePrimer sequence (5′– 3′)Use",
                    "postfix": "-FAGCGATACGUAAAAATGAGTGAACCATTACCAmplification of mlcE from plasmid pEN669mlcE-RCACGCGAUTTATGCATCAGTCTCAGTEF1-dACGTATCGCUGTGAGTCGTATTACGGATCCTTGAmplification of promoter sequence from plasmid pSP-G2PGK1-sCGTGCGAUGCCGCTTGTTTTATATTTGTTGRFP_F+ATGGCCTCCUCCGAGGACGTCATCAAGGAGAmplification of RFP from plasmid pWJ1350RFP_R+CACGCGAUCTAGGCGCCGGTGGAGTGGCGGmlcE-RFP-RAGGAGGCCAUTGCATCAGTCTCAGGGACAmplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1RFP-FAGCGATACGUAAAAATGGCCTCCTCCGAGAmplification of RFP from plasmid pX3-TEF1-mlcE-RFP-CYC1X-3-up-out-sqTGACGAATCGTTAGGCACAGStrain confirmation via colony PCRC1_TADH1_FCTTGAGTAACTCTTTCCTGTAPlasmid nameDescriptionReference or sourcepEN669Template for amplifying mlcE (S. cerevisiae codon optimized)From Evolva Holding SApWJ1350Template for amplifying RFPLisby et al. (2003)pSP-G2Template for amplifying TEF1Partow et al. (2010)pX3USER cloning vector equipped with the CYC1 terminator designed to target site 3 on chromosome X.Mikkelsen et al. (2012)pX3-TEF1-mlcE-CYC1Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "This studypX3-TEF1-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP-tagged mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "This studypX3-TEF1-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP-tagged ",
                    "postfix": " in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "This studypX3-TEF1-mlcE-RFP-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "This studypX3-TEF1-",
                    "postfix": "-CYC1Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study Oligonucleotides, plasmids and strains used in this study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "recA1 endA1",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 ",
                    "postfix": " hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study Oligonucleotides, plasmids and strains used in this study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=recA1 endA1"
                },
                {
                    "name": "phoA supE44",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) ",
                    "postfix": " λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study Oligonucleotides, plasmids and strains used in this study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=phoA supE44"
                },
                {
                    "name": "relA1Woodcock",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 ",
                    "postfix": " et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study Oligonucleotides, plasmids and strains used in this study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=relA1Woodcock"
                }
            ]
        },
        {
            "exact": "mlcE-F AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-F",
                    "prefix": "",
                    "postfix": " AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-F"
                },
                {
                    "name": "mlcE",
                    "prefix": "",
                    "postfix": "-F AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "mlcE-F AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-F",
                    "prefix": "",
                    "postfix": " AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-F"
                },
                {
                    "name": "mlcE",
                    "prefix": "",
                    "postfix": "-F AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "mlcE-F AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-F",
                    "prefix": "",
                    "postfix": " AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-F"
                },
                {
                    "name": "mlcE",
                    "prefix": "",
                    "postfix": "-F AGCGATACGUAAAAATGAGTGAACCATTACC Amplification of mlcE from plasmid pEN669.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "mlcE-R CACGCGAUTTATGCATCAGTCTCAG.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-R",
                    "prefix": "",
                    "postfix": " CACGCGAUTTATGCATCAGTCTCAG.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-R"
                }
            ]
        },
        {
            "exact": "mlcE-R CACGCGAUTTATGCATCAGTCTCAG.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-R",
                    "prefix": "",
                    "postfix": " CACGCGAUTTATGCATCAGTCTCAG.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-R"
                }
            ]
        },
        {
            "exact": "mlcE-R CACGCGAUTTATGCATCAGTCTCAG.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-R",
                    "prefix": "",
                    "postfix": " CACGCGAUTTATGCATCAGTCTCAG.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-R"
                }
            ]
        },
        {
            "exact": "TEF1-d ACGTATCGCUGTGAGTCGTATTACGGATCCTTG Amplification of promoter sequence from plasmid pSP-G2.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "TEF1",
                    "prefix": "",
                    "postfix": "-d ACGTATCGCUGTGAGTCGTATTACGGATCCTTG Amplification of promoter sequence from plasmid pSP-G2.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=TEF1"
                }
            ]
        },
        {
            "exact": "TEF1-d ACGTATCGCUGTGAGTCGTATTACGGATCCTTG Amplification of promoter sequence from plasmid pSP-G2.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "TEF1",
                    "prefix": "",
                    "postfix": "-d ACGTATCGCUGTGAGTCGTATTACGGATCCTTG Amplification of promoter sequence from plasmid pSP-G2.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=TEF1"
                }
            ]
        },
        {
            "exact": "TEF1-d ACGTATCGCUGTGAGTCGTATTACGGATCCTTG Amplification of promoter sequence from plasmid pSP-G2.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "TEF1",
                    "prefix": "",
                    "postfix": "-d ACGTATCGCUGTGAGTCGTATTACGGATCCTTG Amplification of promoter sequence from plasmid pSP-G2.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=TEF1"
                }
            ]
        },
        {
            "exact": "mlcE-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "",
                    "postfix": "-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                },
                {
                    "name": "mlcE",
                    "prefix": "",
                    "postfix": "-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "mlcE-CYC1",
                    "prefix": "mlcE-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-CYC1"
                }
            ]
        },
        {
            "exact": "mlcE-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "",
                    "postfix": "-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                },
                {
                    "name": "mlcE",
                    "prefix": "",
                    "postfix": "-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "mlcE-CYC1",
                    "prefix": "mlcE-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-CYC1"
                }
            ]
        },
        {
            "exact": "mlcE-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "",
                    "postfix": "-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                },
                {
                    "name": "mlcE",
                    "prefix": "",
                    "postfix": "-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-mlcE-CYC1.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                },
                {
                    "name": "mlcE-CYC1",
                    "prefix": "mlcE-RFP-R AGGAGGCCAUTGCATCAGTCTCAGGGAC Amplification of mlcE from plasmid pX3-TEF1-",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-CYC1"
                }
            ]
        },
        {
            "exact": "pEN669 Template for amplifying mlcE (S. cerevisiae codon optimized) From Evolva Holding SA.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "pEN669 Template for amplifying ",
                    "postfix": " (S. cerevisiae codon optimized) From Evolva Holding SA.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pEN669 Template for amplifying mlcE (S. cerevisiae codon optimized) From Evolva Holding SA.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "pEN669 Template for amplifying ",
                    "postfix": " (S. cerevisiae codon optimized) From Evolva Holding SA.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pEN669 Template for amplifying mlcE (S. cerevisiae codon optimized) From Evolva Holding SA.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "pEN669 Template for amplifying ",
                    "postfix": " (S. cerevisiae codon optimized) From Evolva Holding SA.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-mlcE-CYC1 Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-CYC1",
                    "prefix": "pX3-TEF1-",
                    "postfix": " Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-CYC1"
                },
                {
                    "name": "mlcE",
                    "prefix": "pX3-TEF1-",
                    "postfix": "-CYC1 Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-mlcE-CYC1 Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-CYC1",
                    "prefix": "pX3-TEF1-",
                    "postfix": " Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-CYC1"
                },
                {
                    "name": "mlcE",
                    "prefix": "pX3-TEF1-",
                    "postfix": "-CYC1 Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-mlcE-CYC1 Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-CYC1",
                    "prefix": "pX3-TEF1-",
                    "postfix": " Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-CYC1"
                },
                {
                    "name": "mlcE",
                    "prefix": "pX3-TEF1-",
                    "postfix": "-CYC1 Plasmid carrying a gene-targeting cassette for expressing mlcE in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP-tagged mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "pX3-TEF1-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP-tagged ",
                    "postfix": " in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP-tagged mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "pX3-TEF1-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP-tagged ",
                    "postfix": " in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP-tagged mlcE in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "pX3-TEF1-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP-tagged ",
                    "postfix": " in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-mlcE-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "pX3-TEF1-",
                    "postfix": "-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-mlcE-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "pX3-TEF1-",
                    "postfix": "-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "pX3-TEF1-mlcE-RFP-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "pX3-TEF1-",
                    "postfix": "-CYC1 Plasmid carrying a gene-targeting cassette for expressing RFP in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "recA1 endA1",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 ",
                    "postfix": " hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=recA1 endA1"
                },
                {
                    "name": "phoA supE44",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) ",
                    "postfix": " λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=phoA supE44"
                },
                {
                    "name": "relA1",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 ",
                    "postfix": " Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=relA1"
                }
            ]
        },
        {
            "exact": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "recA1 endA1",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 ",
                    "postfix": " hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=recA1 endA1"
                },
                {
                    "name": "phoA supE44",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) ",
                    "postfix": " λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=phoA supE44"
                },
                {
                    "name": "relA1",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 ",
                    "postfix": " Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=relA1"
                }
            ]
        },
        {
            "exact": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "recA1 endA1",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 ",
                    "postfix": " hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=recA1 endA1"
                },
                {
                    "name": "phoA supE44",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) ",
                    "postfix": " λ– thi-1 gyrA96 relA1 Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=phoA supE44"
                },
                {
                    "name": "relA1",
                    "prefix": "DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 ",
                    "postfix": " Woodcock et al. (1989).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=relA1"
                }
            ]
        },
        {
            "exact": "CEN.PK113-11C (Wild type strain) MATα MAL2-8C SUC2 his3Δ ura3-52 Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52",
                    "prefix": "CEN.PK113-11C (Wild type strain) MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": " Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52"
                }
            ]
        },
        {
            "exact": "CEN.PK113-11C (Wild type strain) MATα MAL2-8C SUC2 his3Δ ura3-52 Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52",
                    "prefix": "CEN.PK113-11C (Wild type strain) MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": " Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52"
                }
            ]
        },
        {
            "exact": "CEN.PK113-11C (Wild type strain) MATα MAL2-8C SUC2 his3Δ ura3-52 Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52",
                    "prefix": "CEN.PK113-11C (Wild type strain) MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": " Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52"
                }
            ]
        },
        {
            "exact": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52X3::PTEF1",
                    "prefix": "ARX2 MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": "-RFP-Tcyc1 This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52X3::PTEF1"
                }
            ]
        },
        {
            "exact": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52X3::PTEF1",
                    "prefix": "ARX2 MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": "-RFP-Tcyc1 This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52X3::PTEF1"
                }
            ]
        },
        {
            "exact": "ARX2 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52X3::PTEF1",
                    "prefix": "ARX2 MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": "-RFP-Tcyc1 This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52X3::PTEF1"
                }
            ]
        },
        {
            "exact": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52X3::PTEF1",
                    "prefix": "ARX3 MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": "-mlcE-Tcyc1 This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52X3::PTEF1"
                }
            ]
        },
        {
            "exact": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52X3::PTEF1",
                    "prefix": "ARX3 MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": "-mlcE-Tcyc1 This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52X3::PTEF1"
                }
            ]
        },
        {
            "exact": "ARX3 MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1 This study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "ura3-52X3::PTEF1",
                    "prefix": "ARX3 MATα MAL2-8C SUC2 his3Δ ",
                    "postfix": "-mlcE-Tcyc1 This study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=ura3-52X3::PTEF1"
                }
            ]
        },
        {
            "exact": "Removal of the URA3 marker, via direct repeat recombination, was achieved by growing the strain on SC medium containing 5-fluororotic acid (5-FOA; 740 mg/L, Sigma-Aldrich) and uracil (30 mg/L).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "URA3",
                    "prefix": "Removal of the ",
                    "postfix": " marker, via direct repeat recombination, was achieved by growing the strain on SC medium containing 5-fluororotic acid (5-FOA; 740 mg/L, Sigma-Aldrich) and uracil (30 mg/L).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=URA3"
                }
            ]
        },
        {
            "exact": "Removal of the URA3 marker, via direct repeat recombination, was achieved by growing the strain on SC medium containing 5-fluororotic acid (5-FOA; 740 mg/L, Sigma-Aldrich) and uracil (30 mg/L).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "URA3",
                    "prefix": "Removal of the ",
                    "postfix": " marker, via direct repeat recombination, was achieved by growing the strain on SC medium containing 5-fluororotic acid (5-FOA; 740 mg/L, Sigma-Aldrich) and uracil (30 mg/L).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=URA3"
                }
            ]
        },
        {
            "exact": "Removal of the URA3 marker, via direct repeat recombination, was achieved by growing the strain on SC medium containing 5-fluororotic acid (5-FOA; 740 mg/L, Sigma-Aldrich) and uracil (30 mg/L).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "URA3",
                    "prefix": "Removal of the ",
                    "postfix": " marker, via direct repeat recombination, was achieved by growing the strain on SC medium containing 5-fluororotic acid (5-FOA; 740 mg/L, Sigma-Aldrich) and uracil (30 mg/L).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=URA3"
                }
            ]
        },
        {
            "exact": "Fluorescent microscopy Fluorescent microscopy Fluorescent microscopy For fluorescent microscopy the mlcE-RFP- and RFP-expressing strains (ARX1 and ARX2, respectively) were cultured in liquid SC medium at 30 °C with 150 rpm agitation overnight and analyzed by fluorescence and visible light microscopy using a Nikon Eclipse E1000 microscope equipped with an oil-immersed objective at 100× magnification.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "Fluorescent microscopy Fluorescent microscopy Fluorescent microscopy For fluorescent microscopy the ",
                    "postfix": "- and RFP-expressing strains (ARX1 and ARX2, respectively) were cultured in liquid SC medium at 30 °C with 150 rpm agitation overnight and analyzed by fluorescence and visible light microscopy using a Nikon Eclipse E1000 microscope equipped with an oil-immersed objective at 100× magnification.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "For fluorescent microscopy the mlcE-RFP- and RFP-expressing strains (ARX1 and ARX2, respectively) were cultured in liquid SC medium at 30 °C with 150 rpm agitation overnight and analyzed by fluorescence and visible light microscopy using a Nikon Eclipse E1000 microscope equipped with an oil-immersed objective at 100× magnification.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "For fluorescent microscopy the ",
                    "postfix": "- and RFP-expressing strains (ARX1 and ARX2, respectively) were cultured in liquid SC medium at 30 °C with 150 rpm agitation overnight and analyzed by fluorescence and visible light microscopy using a Nikon Eclipse E1000 microscope equipped with an oil-immersed objective at 100× magnification.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "For fluorescent microscopy the mlcE-RFP- and RFP-expressing strains (ARX1 and ARX2, respectively) were cultured in liquid SC medium at 30 °C with 150 rpm agitation overnight and analyzed by fluorescence and visible light microscopy using a Nikon Eclipse E1000 microscope equipped with an oil-immersed objective at 100× magnification.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-RFP",
                    "prefix": "For fluorescent microscopy the ",
                    "postfix": "- and RFP-expressing strains (ARX1 and ARX2, respectively) were cultured in liquid SC medium at 30 °C with 150 rpm agitation overnight and analyzed by fluorescence and visible light microscopy using a Nikon Eclipse E1000 microscope equipped with an oil-immersed objective at 100× magnification.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-RFP"
                }
            ]
        },
        {
            "exact": "For that, mlcE was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "For that, ",
                    "postfix": " was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-expressing",
                    "prefix": "The ",
                    "postfix": " strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-expressing"
                }
            ]
        },
        {
            "exact": "For that, mlcE was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "For that, ",
                    "postfix": " was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-expressing",
                    "prefix": "The ",
                    "postfix": " strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-expressing"
                }
            ]
        },
        {
            "exact": "For that, mlcE was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "For that, ",
                    "postfix": " was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "The mlcE-expressing strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-expressing",
                    "prefix": "The ",
                    "postfix": " strain showed an increased resistance to mevastatin compared to the reference strain (Fig. 4B).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-expressing"
                }
            ]
        },
        {
            "exact": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-expressing",
                    "prefix": "Again, the ",
                    "postfix": " strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-expressing"
                }
            ]
        },
        {
            "exact": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-expressing",
                    "prefix": "Again, the ",
                    "postfix": " strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-expressing"
                }
            ]
        },
        {
            "exact": "Again, the mlcE-expressing strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE-expressing",
                    "prefix": "Again, the ",
                    "postfix": " strain displays an increased resistance compared to the reference strain, and the putative pump was able to protect the cells against both the natural statin lovastatin and its semi-synthetic derivative simvastatin (Fig. 4B).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE-expressing"
                }
            ]
        },
        {
            "exact": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "max−OD600",
                    "prefix": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,",
                    "postfix": ",t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=max−OD600"
                }
            ]
        },
        {
            "exact": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "max−OD600",
                    "prefix": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,",
                    "postfix": ",t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=max−OD600"
                }
            ]
        },
        {
            "exact": "The liquid culture experiment also allowed for determination of the strains growth efficiencies (Table 2), which revealed that expression of mlcE did have a cost (9% reduction), but that this cost did not change as function of the statin concentration, within the tested concentration range.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "The liquid culture experiment also allowed for determination of the strains growth efficiencies (Table 2), which revealed that expression of ",
                    "postfix": " did have a cost (9% reduction), but that this cost did not change as function of the statin concentration, within the tested concentration range.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "The liquid culture experiment also allowed for determination of the strains growth efficiencies (Table 2), which revealed that expression of mlcE did have a cost (9% reduction), but that this cost did not change as function of the statin concentration, within the tested concentration range.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "The liquid culture experiment also allowed for determination of the strains growth efficiencies (Table 2), which revealed that expression of ",
                    "postfix": " did have a cost (9% reduction), but that this cost did not change as function of the statin concentration, within the tested concentration range.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "The liquid culture experiment also allowed for determination of the strains growth efficiencies (Table 2), which revealed that expression of mlcE did have a cost (9% reduction), but that this cost did not change as function of the statin concentration, within the tested concentration range.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "The liquid culture experiment also allowed for determination of the strains growth efficiencies (Table 2), which revealed that expression of ",
                    "postfix": " did have a cost (9% reduction), but that this cost did not change as function of the statin concentration, within the tested concentration range.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "Conclusions Conclusions We provide evidence that mlcE from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "Conclusions Conclusions We provide evidence that ",
                    "postfix": " from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "We provide evidence that mlcE from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "We provide evidence that ",
                    "postfix": " from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "References Supplementary material Supplementary material Supplementary material Supplementary material Supplementary material Supplementary material Acknowledgments We thank Evolva Holding SA, and Michael Næsby for the financial support to the project, i.e. de novo synthesis of the mlcE gene.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-gene-name",
            "tags": [
                {
                    "name": "mlcE",
                    "prefix": "References Supplementary material Supplementary material Supplementary material Supplementary material Supplementary material Supplementary material Acknowledgments We thank Evolva Holding SA, and Michael Næsby for the financial support to the project, i.e. de novo synthesis of the ",
                    "postfix": " gene.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=mlcE"
                }
            ]
        },
        {
            "exact": "Construction of Saccharomyces cerevisiae cell factory for the production of high concentrations of natural statins will require establishment of a non-destructive self-resistance mechanism to overcome the undesirable growth inhibition effects of statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiae",
                    "prefix": "Construction of ",
                    "postfix": " cell factory for the production of high concentrations of natural statins will require establishment of a non-destructive self-resistance mechanism to overcome the undesirable growth inhibition effects of statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiae"
                }
            ]
        },
        {
            "exact": "To establish active export of statins from yeast, and thereby detoxification, we integrated a putative efflux pump-encoding gene mlcE from the mevastatin-producing Penicillium citrinum into the S. cerevisiae genome.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Penicillium citrinum",
                    "prefix": "To establish active export of statins from yeast, and thereby detoxification, we integrated a putative efflux pump-encoding gene mlcE from the mevastatin-producing ",
                    "postfix": " into the S. cerevisiae genome.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Penicillium citrinum"
                },
                {
                    "name": "S. cerevisiae",
                    "prefix": "To establish active export of statins from yeast, and thereby detoxification, we integrated a putative efflux pump-encoding gene mlcE from the mevastatin-producing Penicillium citrinum into the ",
                    "postfix": " genome.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from ",
                    "postfix": " in S. cerevisiae.•MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                },
                {
                    "name": "S. cerevisiae.•",
                    "prefix": "Highlights •Yeast-based cell factory for statin production will require a resistance mechanism.•We expressed putative efflux pump mlcE from P. citrinum in ",
                    "postfix": "MlcE is a transmembrane protein that localizes to the yeast plasma membrane.•MlcE significantly increases the yeast resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae.•"
                }
            ]
        },
        {
            "exact": "We expressed putative efflux pump mlcE from P. citrinum in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "We expressed putative efflux pump mlcE from ",
                    "postfix": " in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                },
                {
                    "name": "S. cerevisiae",
                    "prefix": "We expressed putative efflux pump mlcE from P. citrinum in ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Penicillium citrinum",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by ",
                    "postfix": " (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Penicillium citrinum"
                },
                {
                    "name": "Aspergillus terreus",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by ",
                    "postfix": " (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Aspergillus terreus"
                },
                {
                    "name": "Monascus ruber",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and ",
                    "postfix": " (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Monascus ruber"
                }
            ]
        },
        {
            "exact": "Production limitations associated with the unique physiology and morphology of these natural producers can be overcome by heterologous expression of the biosynthetic pathway in a fast-growing host, such as Saccharomyces cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiae",
                    "prefix": "Production limitations associated with the unique physiology and morphology of these natural producers can be overcome by heterologous expression of the biosynthetic pathway in a fast-growing host, such as ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiae"
                }
            ]
        },
        {
            "exact": "1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "M. ruber",
                    "prefix": "(B) Lovastatin and its gene clusters from ",
                    "postfix": " (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=M. ruber"
                },
                {
                    "name": "A. terreus",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and ",
                    "postfix": " (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Penicillium citrinum",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by ",
                    "postfix": " (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Penicillium citrinum"
                },
                {
                    "name": "Aspergillus terreus",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by ",
                    "postfix": " (Alberts et al., 1980) and Monascus ruber (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Aspergillus terreus"
                },
                {
                    "name": "Monascus ruber",
                    "prefix": "Natural statins are synthesized as secondary metabolites by filamentous fungi; mevastatin (Fig. 1A) by Penicillium citrinum (Endo et al., 1976), and lovastatin (Fig. 1B) by Aspergillus terreus (Alberts et al., 1980) and ",
                    "postfix": " (Endo, 1979).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Monascus ruber"
                }
            ]
        },
        {
            "exact": "Production limitations associated with the unique physiology and morphology of these natural producers can be overcome by heterologous expression of the biosynthetic pathway in a fast-growing host, such as Saccharomyces cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiae",
                    "prefix": "Production limitations associated with the unique physiology and morphology of these natural producers can be overcome by heterologous expression of the biosynthetic pathway in a fast-growing host, such as ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiae"
                }
            ]
        },
        {
            "exact": "1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "M. ruber",
                    "prefix": "(B) Lovastatin and its gene clusters from ",
                    "postfix": " (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=M. ruber"
                },
                {
                    "name": "A. terreus",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and ",
                    "postfix": " (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Fig. 1 Fig. 1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Fig. 1 Fig. 1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "M. ruber",
                    "prefix": "(B) Lovastatin and its gene clusters from ",
                    "postfix": " (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=M. ruber"
                },
                {
                    "name": "A. terreus",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and ",
                    "postfix": " (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Fig. 1 Fig. 1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Fig. 1 Fig. 1Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "M. ruber",
                    "prefix": "(B) Lovastatin and its gene clusters from ",
                    "postfix": " (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=M. ruber"
                },
                {
                    "name": "A. terreus",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and ",
                    "postfix": " (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Fig. 1 Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Fig. 1 Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "M. ruber",
                    "prefix": "(B) Lovastatin and its gene clusters from ",
                    "postfix": " (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=M. ruber"
                },
                {
                    "name": "A. terreus",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and ",
                    "postfix": " (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from P. citrinum.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Natural statins and their biosynthetic gene cluster: (A) Mevastatin and its gene cluster from ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and A. terreus (lov genes).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "M. ruber",
                    "prefix": "(B) Lovastatin and its gene clusters from ",
                    "postfix": " (mok genes) and A. terreus (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=M. ruber"
                },
                {
                    "name": "A. terreus",
                    "prefix": "(B) Lovastatin and its gene clusters from M. ruber (mok genes) and ",
                    "postfix": " (lov genes).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "A. terreus",
                    "prefix": "Hutchinson et al. found that ",
                    "postfix": " lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as ",
                    "postfix": ", thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Hutchinson et al. found that A. terreus lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "A. terreus",
                    "prefix": "Hutchinson et al. found that ",
                    "postfix": " lovI mutants did not produce lovastatin or any of its known precursors, and that heterologous expression of lovI in Aspergillus nidulans, a lovastatin sensitive species, did not result in increased lovastatin resistance (unpublished result in Hutchinson et al., 2000).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as S. cerevisiae, thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Moreover, genes encoding for the statin transporters can represent a pool of candidates for co-expression in a heterologous host, such as ",
                    "postfix": ", thus open up a possibility to establish the necessary self-resistance mechanism for the production of statins in yeast.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "In this study, we investigate the function of the putative efflux pump MlcE from the ",
                    "postfix": " mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                },
                {
                    "name": "S. cerevisiae",
                    "prefix": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "In this study, we investigate the function of the putative efflux pump MlcE from the ",
                    "postfix": " mevastatin gene cluster and explore its potential to confer statin resistance in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                },
                {
                    "name": "S. cerevisiae",
                    "prefix": "In this study, we investigate the function of the putative efflux pump MlcE from the P. citrinum mevastatin gene cluster and explore its potential to confer statin resistance in ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Construction of plasmids and strains Construction of plasmids and strains Construction of plasmids and strains A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Construction of plasmids and strains Construction of plasmids and strains Construction of plasmids and strains A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The ",
                    "postfix": " TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "The linear gene targeting cassettes were integrated into the X-3 locus of the reference yeast strain, S. cerevisiae CEN.PK 113-11C as described by Mikkelsen et al. (2012).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae CEN.PK 113-11C",
                    "prefix": "The linear gene targeting cassettes were integrated into the X-3 locus of the reference yeast strain, ",
                    "postfix": " as described by Mikkelsen et al. (2012).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae CEN.PK 113-11C"
                }
            ]
        },
        {
            "exact": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiaeCEN.PK113",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)",
                    "postfix": "-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiaeCEN.PK113"
                }
            ]
        },
        {
            "exact": "The linear gene targeting cassettes were integrated into the X-3 locus of the reference yeast strain, S. cerevisiae CEN.PK 113-11C as described by Mikkelsen et al. (2012).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae CEN.PK 113-11C",
                    "prefix": "The linear gene targeting cassettes were integrated into the X-3 locus of the reference yeast strain, ",
                    "postfix": " as described by Mikkelsen et al. (2012).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae CEN.PK 113-11C"
                }
            ]
        },
        {
            "exact": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiaeCEN.PK113",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)",
                    "postfix": "-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study A yeast codon-optimized version of the mlcE gene, de novo synthetized by Genscript, was PCR amplified from the plasmid pEN669 with primers mlcE-F and mlcE-R. The S. cerevisiae TEF1 promoter was amplified from the plasmid pSP-G2 (Partow et al., 2010) using primers TEF1-d and PGK1-s.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiaeCEN.PK113"
                }
            ]
        },
        {
            "exact": "The linear gene targeting cassettes were integrated into the X-3 locus of the reference yeast strain, S. cerevisiae CEN.PK 113-11C as described by Mikkelsen et al. (2012).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae CEN.PK 113-11C",
                    "prefix": "The linear gene targeting cassettes were integrated into the X-3 locus of the reference yeast strain, ",
                    "postfix": " as described by Mikkelsen et al. (2012).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae CEN.PK 113-11C"
                }
            ]
        },
        {
            "exact": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)Saccharomyces cerevisiaeCEN.PK113-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study Oligonucleotides, plasmids and strains used in this study.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiaeCEN.PK113",
                    "prefix": "This studyStrain nameGenotypeReference or sourceEscherichia coliDH5αF– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1Woodcock et al. (1989)",
                    "postfix": "-11C (Wild type strain)MATα MAL2-8C SUC2 his3Δ ura3-52Dr. Petter Kötter, Institut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, GermanyARX1MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1­mlcE-RFP-Tcyc1This studyARX2MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-RFP-Tcyc1This studyARX3MATα MAL2-8C SUC2 his3Δ ura3-52X3::PTEF1-mlcE-Tcyc1This study Oligonucleotides, plasmids and strains used in this study.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiaeCEN.PK113"
                }
            ]
        },
        {
            "exact": "pEN669 Template for amplifying mlcE (S. cerevisiae codon optimized) From Evolva Holding SA.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "pEN669 Template for amplifying mlcE (",
                    "postfix": " codon optimized) From Evolva Holding SA.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "pEN669 Template for amplifying mlcE (S. cerevisiae codon optimized) From Evolva Holding SA.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "pEN669 Template for amplifying mlcE (",
                    "postfix": " codon optimized) From Evolva Holding SA.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "pEN669 Template for amplifying mlcE (S. cerevisiae codon optimized) From Evolva Holding SA.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "pEN669 Template for amplifying mlcE (",
                    "postfix": " codon optimized) From Evolva Holding SA.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Saccharomyces cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiae",
                    "prefix": "",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiae"
                }
            ]
        },
        {
            "exact": "Saccharomyces cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiae",
                    "prefix": "",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiae"
                }
            ]
        },
        {
            "exact": "Saccharomyces cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "Saccharomyces cerevisiae",
                    "prefix": "",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=Saccharomyces cerevisiae"
                }
            ]
        },
        {
            "exact": "Susceptibility experiments Susceptibility experiments Susceptibility experiments For susceptibility assays on solid media tenfold dilution series of S. cerevisiae WT and ARX3 strains (Table 1), starting with an OD600 of 0.02 were prepared from overnight cultures in SC medium (30 °C/150 rpm).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Susceptibility experiments Susceptibility experiments Susceptibility experiments For susceptibility assays on solid media tenfold dilution series of ",
                    "postfix": " WT and ARX3 strains (Table 1), starting with an OD600 of 0.02 were prepared from overnight cultures in SC medium (30 °C/150 rpm).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "For susceptibility assays on solid media tenfold dilution series of S. cerevisiae WT and ARX3 strains (Table 1), starting with an OD600 of 0.02 were prepared from overnight cultures in SC medium (30 °C/150 rpm).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "For susceptibility assays on solid media tenfold dilution series of ",
                    "postfix": " WT and ARX3 strains (Table 1), starting with an OD600 of 0.02 were prepared from overnight cultures in SC medium (30 °C/150 rpm).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "For susceptibility assays on solid media tenfold dilution series of S. cerevisiae WT and ARX3 strains (Table 1), starting with an OD600 of 0.02 were prepared from overnight cultures in SC medium (30 °C/150 rpm).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "For susceptibility assays on solid media tenfold dilution series of ",
                    "postfix": " WT and ARX3 strains (Table 1), starting with an OD600 of 0.02 were prepared from overnight cultures in SC medium (30 °C/150 rpm).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Triplicate OD600 measurements were taken every 5 min for 24 h. Results and discussion Results and discussion Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Triplicate OD600 measurements were taken every 5 min for 24 h. Results and discussion Results and discussion Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE Topology prediction and phylogenetic clustering of MlcE MlcE, a putative efflux pump from the ",
                    "postfix": " mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "Fig. 2 MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Fig. 2 MlcE, a putative efflux pump from the ",
                    "postfix": " mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "Fig. 2 MlcE, a putative efflux pump from the P. citrinum mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Fig. 2 MlcE, a putative efflux pump from the ",
                    "postfix": " mevastatin biosynthetic gene cluster shows significant sequence similarity to drug resistance proteins of the major facilitator superfamily (MFS) (Marger and Saier, 1993).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                }
            ]
        },
        {
            "exact": "Subcellular localization of MlcE Subcellular localization of MlcE Subcellular localization of MlcE To experimentally determine the subcellular localization of MlcE in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Subcellular localization of MlcE Subcellular localization of MlcE Subcellular localization of MlcE To experimentally determine the subcellular localization of MlcE in ",
                    "postfix": " we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "This subcellular localization of MlcE in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "This subcellular localization of MlcE in ",
                    "postfix": " supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Fig. 3Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "3 To experimentally determine the subcellular localization of MlcE in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "3 To experimentally determine the subcellular localization of MlcE in ",
                    "postfix": " we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "This subcellular localization of MlcE in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "This subcellular localization of MlcE in ",
                    "postfix": " supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Fig. 3Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "3 To experimentally determine the subcellular localization of MlcE in S. cerevisiae we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "3 To experimentally determine the subcellular localization of MlcE in ",
                    "postfix": " we tagged MlcE with the red fluorescent protein (RFP) at its carboxylic terminus and expressed it as a single copy gene from the yeast genome (Fig. 3A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "This subcellular localization of MlcE in S. cerevisiae supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "This subcellular localization of MlcE in ",
                    "postfix": " supports the hypothesis that MlcE is a transmembrane protein, which is localized to the plasma membrane.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Fig. 3Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "3 Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "3 Fig. 3Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "3 Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "3 Fig. 3Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "3 Fig. 3Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "3 Fig. 3Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).Fig.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "3 Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "3 Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Subcellular localization of MlcE in S. cerevisiae: (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Subcellular localization of MlcE in ",
                    "postfix": ": (A) strain construction summary and (B) fluorescent microscopy of the constructed strains (see Section 2 for experimental details).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": " Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae We next tested if the localization of MlcE to the yeast plasma membrane would enable it to export statins from yeast, and thereby increase the yeast's resistance to statins.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "For that, mlcE was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "For that, mlcE was expressed from a defined genomic locus in ",
                    "postfix": " as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "4Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "For that, mlcE was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "For that, mlcE was expressed from a defined genomic locus in ",
                    "postfix": " as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "4Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "For that, mlcE was expressed from a defined genomic locus in S. cerevisiae as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "For that, mlcE was expressed from a defined genomic locus in ",
                    "postfix": " as a single copy gene under the control of the strong constitutive promoter TEF1 (Fig. 4A).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "4Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "4 Fig. 4Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "4 Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "4 Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Investigation of the potential of MlcE to confer the resistance to statins in S. cerevisiae: (A) strain construction summary and (B) susceptibility assay.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Investigation of the potential of MlcE to confer the resistance to statins in ",
                    "postfix": ": (A) strain construction summary and (B) susceptibility assay.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory Statins are currently commercially produced by fermentation of natural statin-producing species of filamentous fungi.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "MlcE and a future ",
                    "postfix": " based statin cell factory MlcE and a future S. cerevisiae based statin cell factory MlcE and a future S. cerevisiae based statin cell factory Statins are currently commercially produced by fermentation of natural statin-producing species of filamentous fungi.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "For the last decade several groups have been working on establishing ",
                    "postfix": " based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "However, no one has yet reported whether S. cerevisiae will be able to cope with the required product levels.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "However, no one has yet reported whether ",
                    "postfix": " will be able to cope with the required product levels.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of ",
                    "postfix": " strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "For the last decade several groups have been working on establishing ",
                    "postfix": " based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "However, no one has yet reported whether S. cerevisiae will be able to cope with the required product levels.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "However, no one has yet reported whether ",
                    "postfix": " will be able to cope with the required product levels.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of ",
                    "postfix": " strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "For the last decade several groups have been working on establishing S. cerevisiae based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "For the last decade several groups have been working on establishing ",
                    "postfix": " based statin cell factories, and in 2013, Xu et al. succeed in producing dihydromonacolin L acid (0.11 mM), the first stable intermediate in the lovastatin pathway (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "However, no one has yet reported whether S. cerevisiae will be able to cope with the required product levels.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "However, no one has yet reported whether ",
                    "postfix": " will be able to cope with the required product levels.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "1 mM (less than half of the required concentration) in the wild type and that even low concentrations of lovastatin greatly reduced the aerobic maximum specific growth rate and final optical density (Table 2).Table 2Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of ",
                    "postfix": " strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of ",
                    "postfix": " strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of S. cerevisiae strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Aerobic maximum specific growth rates and growth efficiencies calculated as Δ(OD600,max−OD600,t=0) of ",
                    "postfix": " strains WT (CEN.PK 113-11C) and ARX3 (harboring MlcE efflux pump) on glucose and different concentrations of activated lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "The analysis showed that while the growth of ",
                    "postfix": " wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                },
                {
                    "name": "A. terreus",
                    "prefix": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of ",
                    "postfix": ", growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "The analysis showed that while the growth of ",
                    "postfix": " wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                },
                {
                    "name": "A. terreus",
                    "prefix": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of ",
                    "postfix": ", growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "The analysis showed that while the growth of ",
                    "postfix": " wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of A. terreus, growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                },
                {
                    "name": "A. terreus",
                    "prefix": "The analysis showed that while the growth of S. cerevisiae wild type strain was almost completely inhibited at lovastatin concentrations similar to those achieved by fermentation of ",
                    "postfix": ", growth of the ARX3 strain was only slightly affected by the same high concentration of lovastatin.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=A. terreus"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Direct proof of the effects of implementing the MlcE based resistance in a ",
                    "postfix": " statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Direct proof of the effects of implementing the MlcE based resistance in a ",
                    "postfix": " statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Direct proof of the effects of implementing the MlcE based resistance in a S. cerevisiae statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "S. cerevisiae",
                    "prefix": "Direct proof of the effects of implementing the MlcE based resistance in a ",
                    "postfix": " statin cell factory is currently not possible as only part of the biosynthetic pathway at this time has been established in yeast (Xu et al., 2013).",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "Conclusions Conclusions We provide evidence that mlcE from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "Conclusions Conclusions We provide evidence that mlcE from the ",
                    "postfix": " mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                },
                {
                    "name": "S. cerevisiae",
                    "prefix": "Conclusions Conclusions We provide evidence that mlcE from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        },
        {
            "exact": "We provide evidence that mlcE from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
            "section": "Methods (http://purl.org/orb/Methods)",
            "type": "bgc-organism",
            "tags": [
                {
                    "name": "P. citrinum",
                    "prefix": "We provide evidence that mlcE from the ",
                    "postfix": " mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in S. cerevisiae.",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=P. citrinum"
                },
                {
                    "name": "S. cerevisiae",
                    "prefix": "We provide evidence that mlcE from the P. citrinum mevastatin biosynthetic gene cluster encodes a transmembrane protein that localizes to the plasma and vacuolar membranes in ",
                    "postfix": ".",
                    "uri": "https://www.ebi.ac.uk/ols/search?q=S. cerevisiae"
                }
            ]
        }
    ]
}